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Generalised osteoarthritis (OA) is a common disorder of the joints which can lead to 
pain and disability. Identification of the determinant gene(s) is limited in part by the 
lack of Mendelian inheritance in most forms of the disorder, the combination of 
genetic and environmental influences and the late development of the condition. An 
approach to the investigation of the aetiology of OA would be to take advantage of 
the monogenic basis of inherited skeletal dysplasias in which OA is a major 
component. For this reason, the molecular genetic basis of the epiphyseal dysplasias, 
which encompass a spectrum of phenotypes ranging from mild to severe skeletal 
involvement, is addressed in this thesis. Familial skeletal disorders in South Africa in 
which OA is a major feature were identified and investigated using intragenic and 
closely linked microsatellite markers in order to determine linkage to candidate genes. 
Mutational analysis was undertaken to identify the genetic defect. 
The candidate genes were selected on the basis of the involvement of their products in 
the structural integrity of articular cartilage, the primary tissue which is affected in the 
osteoarthropathies. The most likely candidate for the epiphyseal dysplasias was the 
COL2A 1 gene, which encodes type II collagen, the major component of articular 
cartilage. Other candidate genes in the present investigation included those encoding 
the minor collagenous components, namely, types IX and XI collagen, the genes 
encoding the collagen of the gro\\1h plate, type X collagen and those encoding the 
Vll 
the collagen of the growth plate, type X collagen and those encoding the type VI 
collagen monomers. Screening of the genes encoding the proteoglycans aggrecan, 
decorin, fibromodulin and lumican, and the genes encoding other non-collagenous 
proteins of the extracellular matrix such as cartilage oligomeric matrix protein, 
cartilage link protein, cartilage matrix protein, chondrocalcin and matrix 
metalloproteinase 3, was also undertaken. 
In some of the rare epiphyseal dysplasias, phenotypic features include high myopia 
and deafness, as in the Stickler syndrome type 1. In the present study, a COL2Al 
haplotype was found to cosegregate with a condition resembling Stickler syndrome 
type 1 in an Afrikaner family which also manifested atypical brachydactyly. The 
underlying molecular defect proved to be a C2503T transition which resulted in an 
Arg704Cys substitution. The mildness of the condition in this family, compared to 
the greater skeletal involvement in other SED phenotypes which are caused by Arg-
Cys substitutions, could possibly be attributed to the variant position of the change 
within the Gly-X-Y repeat of the triple helix. 
The COL2A 1 gene was also implicated in two large kindreds from the western Cape 
province who exhibited a form of spondyloepiphyseal dysplasia (SED). These 
respective disorders, SED type Cape Town (SEDCT) and Namaqualand SED 
(NSED), both presented with dysplasia of the femoral capital epiphyses and severe 
secondary degenerative OA which developed in early adulthood. The clinical and 
radiographic phenotypes in both families were similar, differing only in the respective 
stature of the affected individuals. The disorder in each kindred was found to 
cosegregate with the same COL2Al haplotype. Mutation analysis revealed a 
Gly472Cys substitution in the triple helix of the type II collagen protein in affected 
persons from both families. The common mutation implies that these two conditions 
are the same entity and that a founder effect is operative. 
In another family with the mild, Ribbing type of multiple epiphyseal dysplasia 
(MED), no recombinants were found using markers close to the COMP gene. 
Vlll 
Mutation screening revealed a C1594G transversion in exon 14 which encodes a 
calmodulin-like repeat of the COMP molecule. The mutation resulted in an 
Asn523Lys substitution which is thought to alter the calcium binding capacity of the 
COMP molecule. 
Familial primary generalised OA (FOA) in a large family was investigated for linkage 
to eighteen possible candidate genes. Of those, twelve were excluded on the basis of 
LOD scores <-2.00 at theta=0.00 and meiotic recombination, from being involved in 
the aetiology of the condition. The involvement of the other six genes could not be 
determined conclusively. The findings of this investigation indicate that a potential 
candidate for FOA may exist at a locus within 5cM of the COLl lAl gene. 
Mseleni joint disease (MID) is a severe form of OA which has an unusually high 
incidence in a geographically isolated population. An association to candidate genes 
expressed in cartilage, was investigated by comparing allele frequencies in affected 
and unaffected groups of people from the Mseleni district. Although there was no 
obvious linkage disequilibrium with the candidate genes, an increased homozygosity 
for the alleles of an intragenic COL9Al marker was observed and warrants further 
investigation. Histological analysis showed an accumulation of type VI collagen 
around the chondrocytes. 
Although no clear conclusions can be drawn concerning the overall contribution of 
genetics to the common form of OA in the population, the findings presented in this 
thesis will contribute towards the understanding of the different genes which are 
involved in OA and the mechanisms by which the condition can arise. These 
molecular findings also provide a means of management in the affected individuals 
by virtue of presymptomatic diagnosis and planning suitable lifestyles for individuals 
who are at risk of manifesting these skeletal dysplasias. 
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CHAPTER 1: GENERAL INTRODUCTION 
CHAPTER 2: LITERATURE REVIEW 
CHAPTER 1: 
GENERAL INTRODUCTION 
" ... our knowledge of the disease is incomplete, perhaps because it is one of those 
dull commonplace disorders that are hard to study with enthusiasm, but new 
knowledge of osteoarthritis must be gained if the later years of our lengthening lives 
are not to be plagued by increasing pain and disability". 
JH Kellgren, 1961 
Osteoarthritis (OA) is the end result of a number of pathophysiological processes, 
hereditary or environmental, which all have a common pathway of cartilage 
destruction. It is a common disorder of joints which, in many instances, causes 
progressive loss of motion. Despite considerable progress in the understanding of OA 
over the past three decades, there is still a pressing need to unravel the aetiology of 
the condition, in order to identify risk factors for the development and progression of 
OA, and to devise primary prevention strategies. 
The available evidence suggests that genetic factors have a major role in OA. The 
nature of the genetic influence is, however, speculative and may involve a structural 
defect, alterations in cartilage or a genetic influence on a known risk factor. The role 
of genetic factors in the development of OA has attracted extensive research which 
has been facilitated by the advances in molecular biology. 
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Because of the difficulty in separating out the individual factors which contribute 
towards the phenotype of a multicomponent condition such as OA, researchers have 
often opted to study monogenic disorders in which OA is a major feature, but which 
show clear mendelian inheritance. The advantage of investigating these latter 
conditions is that they result from a single gene defect and thus provide the best 
approach to isolating the different mechanisms which can contribute toward OA. 
The general opinion of researchers in this field is that genetic studies of well-
characterised families expressing common forms of OA, may give important, 
possibly novel, insights into pathogenesis. In this regard, the present South African 
study involved the investigation of kindred with rare skeletal dysplasias in which 
OA is a component. 
1.1. PLAN OF THE THESIS 
This thesis is divided into eight chapters. The first chapter provides an introductory 
background to the osteoarthropathies and provides a general overview of the aim of 
the study and the scientific approach to the investigation. 
The second chapter introduces articular cartilage which is assumed to be defective in 
the osteoarthropathies. The role of the various candidate genes in the aetiology of 
skeletal abnormalities is discussed, thus providing scientific reason for nominating 
them as candidates for the genetic conditions covered by this thesis. In Chapters 3-7 
each of the unique osteoarthropathies encountered in the South African population is 
discussed separately, providing background information on the clinical and 
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radiological findings and discussing the molecular investigations undertaken in 
this project. The thesis is concluded in the eighth chapter, where the findings of the 
molecular studies in the South African families are summarised and the scientific 
contribution which these investigations have made towards our understanding of 
OA, is discussed. Future prospects for further investigations are addressed. 
1.2. INTRODUCTORY BACKGROUND TO 
OSTEOARTHROPATHY(OA) 
Generalised OA is a degenerative disorder which affects multiple bones and 
joints, the most commonly affected being the large weight-bearing joints such as 
the hips and knees together with the hands, spine and feet. The condition is 
characterised by destructive lesions in articular cartilage which progresses to a 
loss of this tissue and may eventually lead to exposure of the subchondral bone 
(Fig.1.1 ). 
Osteoarthropathy is not a single entity but could be regarded as the final common 
pathway of cartilage degradation [Freeman, 1980]. The aetiology of the common, 
ostensibly non-genetic form of OA is unknown but epidemiologic studies have 
revealed a relationship between age and other contributing factors such as 
occupation and lifestyle [Mankin et al., 1986; Hochberg, 1991; Felson, 1993; 
Tikly, 1994]. The issue surrounding the heritability of generalised OA is 
controversial and has sparked much debate. For a long time, it was considered that 
familial QA was secondary to the effects of skeletal abnormalities or 




Fig. I. I. Photographs comparing the morphology of the articular cartilage surface of 
femoral heads from hip specimens (a) with and (b) without osteoarthropathy. The 
erosion of the articular cartilage down to the subchondral bone is depicted in (a) 
(white arrow- original remaining cartilage; black arrow - eroded region). The hip 
specimens were obtained at the time of hip replacement surgery and postmortem, 
respectively. 
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accumulated to suggest, however, that an inherited predisposition may be an 
important factor in the development and progression of some forms of generalised 
OA [Stecher et al., 1953; Kellgren et al., 1963; Prockop et al., 1997]. Much 
know ledge has been gained concerning the structural collagenous and non-
collagenous components of articular cartilage and their disruption in some disorders. 
This thesis was undertaken to investigate, at a molecular level, the aetiology of 
familial chondrodysplasias of which OA is a major feature, which had been 
encountered in the South African population. 
1.3. THE PROBLEM TO BE INVESTIGATED: FAMILIAL OA 
IN SOUTH AFRICA 
Conventional "non-genetic" generalised OA is as prevalent in the elderly South 
African population as it is worldwide, affecting 15-20% of people over the age of 50 
years [Reynolds et al., 1992]. In addition, several large southern African kindreds 
suffer from early onset familial degenerative arthropathy of the hip [ du Toit, 1979; 
Beighton et al., 1984; Ramesar and Beighton., 1992]. 
The different inherited osteoarthropathies vary from each other by virtue of their 
natural history and the anatomical distribution of the joints which are affected. All 
except one of the conditions chosen for this study follow an autosomal dominant 
pattern of inheritance and are therefore perpetuated from generation to generation, 
affecting large numbers of individuals within the kindreds. The following conditions 
in this category have been investigated: Namaqualand Hip dysplasia (NSED), 
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spondyloepiphyseal dysplasia type Cape Town (SEDCT), multiple epiphyseal 
dysplasia (MED) and a syndrome resembling arthro-ophthalmopathy (Stickler 
syndrome type I). A familial form of autosomal dominant osteoarthropathy (termed 
FOA for the purposes of this study) with no other syndromic features and affecting 
several individuals in a large family, has also been investigated. Another disorder 
which has been addressed in this study, is Mseleni joint disease (termed MID for the 
purposes of this study). This disorder is a severe, chronic form of OA encountered in 
southern Africa, which affects several hundred people within a small remote region 
of the province of Kwa-Zulu Natal in South Africa. Although MID clusters in 
families, it does not have a clear Mendelian pattern of inheritance. 
1.4. THE AIM OF THIS STUDY 
The aim of this study was to elucidate the molecular genetic basis of disease in 
familial forms of OA in the South African population. In order to achieve this 
objective, investigations were undertaken to determine whether the OA phenotypes 
were associated with candidate genes which code for the major components of 
articular cartilage. Thereafter the genes in question were screened for disease-
predisposing mutations. The goal of this study was therefore to identify the defective 
gene and characterise the pathogenic mutation in each of the osteoarthropathies to be 
investigated. 
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1.5. THE APPROACH TO THIS STUDY 
Inherited forms of skeletal abnormalities have been a focal point of interest in the 
Department of Human Genetics, UCT, for more than 25 years. Numerous 
families and sporadic individuals with skeletal abnormalities had been 
documented at clinics during that period. Affected individuals were thoroughly 
examined, both clinically and radiologically. In order to determine the extent of 
the skeletal involvement and to make an accurate diagnosis, blood specimens 
were obtained from the available family members and their DNA was banked to 
allow for subsequent molecular investigations. 
In order to pursue molecular analyses, it was necessary, in some instances, to 
obtain blood specimens from additional family members. Molecular 
investigations included linkage analysis to determine whether the OA stigmata 
were cosegregating with any of the candidate genes. This approach involved the 
use of polymorphic intragenic markers for accurate co localization of the disorder 
and candidate gene and in order to reduce the risk of recombinations. 
Microsatellite DNA markers from the vicinity of the chromosomal regions of the 
candidate genes were used if the intragenic marker was not informative or not 
available. Two-point LOD scores were calculated using a computer programme to 
determine whether there was an association between the condition and the DNA 
marker. In those instances where no recombinant events were observed between 
the phenotypic status and DNA markers in family members, the candidate gene in 
that chromosomal region was screened for exonic mutations by single stranded 
conformational polymorphism (SSCP) analysis. Variations from the 
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expected SSCP mobility pattern, suggesting a possible mutation, were verified by 
direct sequencing of the exons. These variants were compared with the known 
nucleic acid sequences and the effect of the sequence change upon the protein 
product was deduced. 
CHAPTER 2: 
LITERATURE REVIEW; THE BIOLOGY OF 
ARTICULAR CARTILAGE 
2.1. GENERAL BACKGROUND 
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Cartilage is a highly specialised avascular structure which is widely distributed in the 
human body and which plays an important role in the formation and growth of the 
skeleton. The cells that produce the cartilage matrix are the chondroblasts or 
chondrocytes. The development of the human skeleton involves two stages: firstly, 
the formation of a cartilage model - a process of cell differentiation and pattern 
formation; secondly, the replacement of this cartilage by bone during endochondral 
ossification - the latter process involves cartilage maturation (hypertrophy), matrix 
degradation, vascular invasion and ossification [Erlebacher et al., 1995]. 
This study is focussed on articular cartilage, which is the thin layer covering the bone 
ends which articulate in joints. The chain of events observed in the development of 
OA is best explained by the assumption that the primary abnormality is in the 
articular cartilage and that all pathological changes in the other joint structures are 
attributable, directly or indirectly, to these cartilage changes. 
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The mechanical properties of cartilage and its ability to withstand pressure and allow 
low friction movement, are determined by its components, which are mainly collagen 
and proteoglycans. During cartilage synthesis the chondrocytes secrete and assemble 
a highly complex extracellular matrix in which the fibrillar collagen framework and 
proteoglycans interact. A dense macromolecular network is created which imparts 
structural integrity and resilience to the cartilage tissue. The most abundant 
macromolecules are type II collagen which comprises about 85% of the total 
collagen content, together with aggregates of aggrecan and hyaluronic acid [Byers, 
1993]. Several other collagens, small proteoglycans and non-collagenous 
components are covalently bound to each other and contribute towards the stability 
of the cartilage matrix. 
2.2. COLLAGENOUS COMPONENTS OF ARTICULAR 
CARTILAGE 
The collagens are a complex family of secreted molecules that share similar triple-
helical domains and are comprised of closely related proteins which are genetically 
distinct [Eyre et al., 1987a]. Cartilage displays an extensive variety of collagen 
types, the most widespread and abundant being the fibrillar collagens viz. types I, II, 
III, V and XI. This thesis will focus on molecular genetic investigations of the 
integrity of the genes encoding types II and XI collagen, as well as those encoding 
the fibril-associated type IX collagen, the network collagen, type X, and type VI 
collagen of microfibrils [Byers, 1993]. 
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The distinctive feature of every collagen molecule is its unique protein structure 
which comprises highly repetitive sequences of amino acids in the format: glycine 
(Gly)-X-Y [Prockop, 1992]. The length of the uninterrupted repeating tripeptide unit 
varies among collagens, ranging from 338 to 341 triplets in the fibril-forming 
proteins, and being considerably shorter in the other collagen subgroups. The amino 
acid in the X position is frequently proline and the Y position is frequently occupied 
by hydroxyproline. The presence of a glycine residue at every third position enables 
the collagen molecule to form a helical structure. The glycine is in the center of the 
triple helix, occupying a restricted space which can only accommodate this small 
amino acid. Glycine does not contain a bulky side group and the chains are able to 
interact with each other at the glycine residues. If the side-chain of any substituting 
amino acid disrupts the triple helix, the consequences are highly deleterious 
[Williams and Jimenez, 1995a; Horton, 1996; Rimoin, 1996] (Table 2-1). 
In order to achieve the tightest fit, the 3 polypeptide chains of the collagen presursor 
fold and twist into the triple helical conformation which is crucial for transport of the 
fibrillar collagens beyond the rough endoplasmic reticulum (RER). The triple helix 
is stabilised by interchain hydrogen bonds between the amide group of glycine and 
the oxygen of the carbonyl group of an amino acid in the X position in an adjacent 
chain. Further stabilisation occurs as a result of hydrogen bonds between the 
hydroxyl group of hydroxyproline and the carbonyl backbone of the chain [Mathews 
and van Holde, 1990]. 
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Each collagen is made up of 3 polypeptide a chains wound into a characteristic left-
handed triple helix. The molecule may be composed of only one type of a chain (i.e. 
a homo trimer as in type II collagen) or 2 or all 3 chains may be different ( collagen 
types VI, IX, XI) [Horton, 1996]. By convention, each of the collagens are identified 
by roman numerals and the individual a chains of the triple helices are represented 
by arabic numerals. Categorisation of the collagens is based on their a chain 
characteristics, molecular assembly and supramolecular structures [Murray, 1986]. 
2.2.1. Type II collagen 
This is the major collagenous component of all hyaline cartilage, nucleus pulposus 
and vitreous humour [Ayad et al., 1994]. It forms the network of fibrils upon which 
the other matrix components can be deposited [Mayne, 1989]. Type II collagen is a 
homo trimer containing three identical a 1 (II) chains which form a continuous triple 
helix. Chondrocytes are the main cells expressing the single gene, COL2Al, which 
encodes all 3 chains of the helical molecule. COL2Al has been localised to 
12ql3.l l-q13.12 [Takahashi et al., 1990] between the microsatellite markers 
D12S331 and D12S339 (The Human Gene Map http:/ /www.ncbi.nlm.nih.gov/cgi-
bin/SCIENCE96; Fig. 2-1 ). The combined efforts of a number of investigators has 
led to the elucidation of the structure of the COL2Al gene [Strom and Upholt, 1984; 
Cheah et al., 1985; Sangiorgio et al., 1985; Vikkula and Peltonen et al., 1989; Ala-
Kokko and Prockop, 1990]. 
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Fig. 2-1. Representation of 12ql3.11-q13.12 and the approximate location of the microsatellite 
markers (within 5cM of the candidate region for the COL2Al gene) which were used to show 
linkage to COL2Al. The genetic distances between the markers (shaded) and relative to other 
markers, are shown in Kosambi centimorgans (KcM). This figure incorporates data taken from 
GDB (http://www.gdb.org). 
The gene is about 30kb in size and transcribes into a 6kb mRNA transcript. The 54 
exons encode three functional protein domains: exons 1 to 6 encode the N-terminal 
propeptide, exons 6-49 encode the triple helical domain, and exons 49 to 52 
encode the C-terminal propeptide. All exons encoding the main triple helix contain 
54bp or multiples thereof. Furthermore, the exons contain complete codons and 
encode complete Gly-X-Y triplets [Cole, 1994]. An intragenic VNTR in the 3' 
untranslated region of the gene [Stoker et al., 1985] and two closely linked 
markers, D12S361 and D12S368, were used for linkage in the present study. 
Mutations in the COL2Al gene have been implicated in skeletal dysplasias which 
involve the tissues where the type II collagen gene is expressed. The type II 
collagenopathies now include the entire family of spondylo-epiphyseal dysplasias 
(SEDs) which involves the spine and epiphyses. These conditions comprise an 
extensive spectrum of phenotypes ranging from the milder SED forms and the 
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Stickler syndrome to the severe hypochonclrogenesis and achonclrogenesis 
phenotypes [Cole, 1994; Horton, 1996; Rimoin, 1996]. 
The most common type of mutation which occurs in the COL2Al gene appears to 
involve glycine substitutions in the collagen triple helix. Early biochemical studies of 
cartilage from persons with various forms of chonclrodysplasia provided evidence for 
a gradient of phenotypic severity which relates to changes in the triple helix; 
generally, mutations occuring close to the carboxyl terminus result in the more severe 
chonclrodystrophies whereas in milder phenotypes, mutations occurred closer to the 
amino terminus. This gradient is demonstrated in individuals with Gly-Ser 
substitutions which produce phenotypes ranging from severe achonclrogenesis type II 
(Gly691,943Ser) to mild forms of SED with precocious osteoarthritis 
(Gly247,274,443Ser) [Horton et al., 1996]. Some mutations which cause a SED 
phenotype such as Gly895, 997Ser, do not, however, fit the gradient pattern 
[Winterpacht et al., 1995; Chan et al 1991]. 
The mutations which have been described in the COL2Al gene include insertions, 
deletions and base substitutions. Amongst these are the termination mutations which 
result in stop codons within the triple helix. In this instance, the resultant truncated 
collagen monomer cannot be incorporated into the collagen fibre and therefore does 
not have the same deleterious effect of mutant strands which become part of the 
mature collagen molecule. Instead, the loss of collagen monomers, or 
haploinsufficiency, results in Stickler syndrome type 1, which is a mild skeletal 
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dysplasia and is characterised by severe myopia and hearing loss [Zlotogora et al., 
1992]. The COL2Al gene also appears to have mutation hotspots which are prone to 
Arg-Cys substitutions, in particular Arg 75 and Arg 519, that result in a mild form of 
SED with precocious OA [Williams et al., 1995b; Bleasel et al., 1995]. Other type II 
collagenopathies include mild forms of OA ( early and late onset), severe forms of 
chondrodysplasia such as SED congenita and Kniest dysplasia and the lethal 
achondrogenesis type II and hypochondrogenesis phenotypes [Beighton, 1988]. 
2.2.2. Type VI collagen 
Type VI collagen is a short-helical heterotrimer which is widely expressed in 
connective tissue. The molecule is composed of 3 genetically distinct a. chains 
encoded by 3 different genes viz. COL6Al, COL6A2 and COL6A3. The COL6Al 
and COL6A2 genes form a gene cluster within 185kb on 21q22.3 [Weil et al., 1988] 
(Fig. 2-2a) and may be separated by as much as 150kb [Heiskanen et al., 1995]. The 
two genes occur as a gene pair in head-to-tail configuration. The COL6Al gene is 
29kb long (at this time, the exact number of exons is not known) and the COL6A2 
gene is 36kb in length, comprising 30 exons. An intragenic marker and the 
microsatellite markers , D21 S 171 and D2 l S 1446, were selected for analysis in the 
present study. The gene encoding COL6A3 has been localised to a 17cM region on 
2q37 between the markers, D2S336 and D2S395 [The Human Gene Map]. Markers 
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Fig. 2-2a. Representation of 21q22.2-q22.3 and the approximate location of the 
intragenic and microsatellite markers (within 5cM of the candidate region for the 
COL6Al and COL6A2 genes) which were used to show linkage to COL6Al and 
COL6A2. This figure incorporates data taken from GDB (http://www.gdb.org) . 
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Fig. 2-2b. Representation of 2q36-q37 and the approximate location of the 
microsatellite markers (within 5cM of the candidate region for the COL6A3 gene) 
which were used to show linkage to COL6A3. The genetic distances between the 
markers (shaded) and relative to other markers, are shown in Kosambi centimorgans 
(KcM). This figure incorporates data taken from GDB (http://www.gdb.org). 
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Several observations have been made which imply that type VI collagen has a role 
in cell attachment and associates with the major collagen fibrils [Keene et al., 
1988; Jobsis et al., 1996]. It has also been suggested that the type VI collagen 
triple helix is specifically adjusted to form tissue-bound microfibrils which are 
considered to have an anchoring function [Chu et al., 1988]. 
Base substitutions in the a 1 (VI) and a2(VI) collagen chains have been associated 
with Bethlem myopathy, an autosomal dominant disorder with contractures which 
affects skeletal muscle [Jobsis et al., 1996]. In 4 families the mutations involve 
Gly-SerNal changes which disrupt the Gly-X-Y motif of the collagen triple helix. 
The COL6A3 gene product has also been implicated in Bethlem myopathy by 
genetic linkage analysis in a large family [Speer et al., 1996]. 
2.2.3. Type IX collagen 
Type IX collagen belongs to the F ACIT (fibril-associated collagens with 
interrupted triple helices) subfamily of collagens and contains collagenous (C) and 
non-collagenous (NC) domains. The molecule can also be regarded as a 
proteoglycan as some of its forms have glycosarninoglycans attached to their non-
collagenous domains [McCormick et al., 1987]. Type IX collagen is co-distributed 
throughout the extracellular matrix with type II collagen fibrils and may be 
concentrated where the fibrils intersect [Muller-Glauser et al., 1986]. Furthermore, 
type IX collagen may co-polymerise with type II fibrils, and possibly mediates 
physical interaction between collagen fibrils and proteoglycans in cartilage [Eyre 
and Wu, 1995]. It is possible that the incorporation of type IX collagen onto the 
surface of fibrils might serve to control 
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lateral fibril growth and the loss or absence of type IX collagen may result in fibril 
aggregation. Smith and Brandt [1992] proposed that type IX may be an intermediary 
molecule which is necessary for network stabilization. 
The type IX collagen molecule consists of a heterotrimer, with 3 distinct gene 
products which assemble to form a single molecule of chain composition 
al(IX)a2(IX)a3(IX). The gene encoding the al chain, COL9Al, contains 19 exons 
and spans 100kb on the chromosomal region 6q12-q13 [Kimura et al, 1989; Warman 
et al., 1993a]. In the present study, intragenic microsatellite markers, 509-12Bl and 
509-8B2, were used to demonstrate linkage to the gene. The COL9A2 gene has been 
localised to lp32.3-p33 [Warman et al., 1994; Hellsten et al., 1995] between the 
markers D1S255 and D1S2861[The Human Gene Map], and has 32 exons spanning 
about 10kb [Muragaki et al., 1990]. The most informative marker, situated in the 
closely linked MYCLl gene (Fig. 2-3a), was used to show linkage in the present 
study. More recently, the gene encoding COL9A3 was localised to 20q13.3 
[Brewton et al., 1995]; the structure of the gene is unknown. Closely linked markers, 
D20S 171 and D20S64 [Research Genetics] (Fig. 2-3b) were used for linkage analysis 
in the present study. 
The COL9Al gene has been implicated in chondrodysplasias as demonstrated in 
mice with non-inflammatory degenerative joint disease [Fassler et al., 1994]. Further 
confirmation of the importance of the a 1 (IX) chain for normal cartilage function was 
obtained by Hagg et al. [1997] who reported a functional knock-out of the entire type 
IX collagen protein in the absence of the a 1 (IX) chain. 
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Initial studies by Briggs et al. [1994] demonstrated an association between 
COL9A2 and the severe, Fairbank: form, of multiple epiphyseal dysplasia (MED) 
which is characterised by generalised abnormalities of the epiphyses, stunted 
stature and brachydactyly [Fairbank:, 1946]. By identifying a heterozygous 
mutation in a Dutch family with MED, Muragaki et al. [1996] confirmed that 
COL9A2 was a locus for MED. The mutation involved a splice donor site which 
resulted in exon skipping within the triple helical domain of the gene. 
As yet, no chondrodystrophy has been found to be associated with abnormalities 
in COL9A3. 
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Fig. 2-3a. Representation of lp32.3-p33 and the approximate location of the microsatellite 
markers (within 5cM of the candidate region for the COL9A2 gene) which were used to show 
linkage to COL9A2. The genetic distances between the markers (shaded) and relative to other 
markers, shown in Kosambi centimorgans (KcM), were obtained from the CEPH/Genethon 










Fig. 2-3b. Representation of 20q13.2-q13.33 and the approximate location of the 
microsatellite markers (within 10cM of the candidate region for the COL9A3 gene) 
which were used to show linkage to COL9A3. Genetic distances in Kosambi 
centimorgans (KcM) were obtained from the CEPWGenethon linkage map. This figure 
incorporates data taken from GDB (http://www.gdb.org). 
2.2.4. Type X collagen 
Type X collagen is a short-chain, non-fibril forming collagen molecule which is 
expressed in hypertrophic chondrocytes during bone growth [Schmid et al., 1987]. 
The molecule comprises one type of chain and exists as a homotrimer in the 
pericellular matrix of the hypertrophic chondrocytes. The 680 amino acid protein 
is encoded by the COLlOAl gene. The gene, which has been mapped to 6q22.3 
[Apte et al., 1991], spans about 7kb and contains 3 exons [Thomas et al., 1991]. 
In order to demonstrate linkage in the present study, an intragenic point variation 
which introduces a Hindlll restriction site, COLlOAl, was used along with 
microsatellite markers, D6S474 and D6S1639 (Fig. 2-4). 
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The pattern of type X collagen synthesis and its distribution at the sites of 
cartilage calcification, suggests that it plays a role in the development of the 
growth plate and in the calcification of cartilage [Gordon and Olsen 1990; Kwan 
et al., 1991]. 
Heterozygous mutations of conserved amino acids in the carboxy (C)-propeptide 
region of COLlOAl have been identified in Schmid metaphyseal dysplasia 
(MCDS) [Warman et al., 1993b; Wallis et al., 1996], an autosomal dominant 
skeletal dysplasia characterised by short stature, short limbs and bowed legs 
[Dharmavaram et al., 1994]. The mutations affect the integrity of the carboxyl 
terminus which is responsible for the association of the collagen chains and the 
assembly of the triple helix [McIntosh et al., 1994; Chan et al., 1998]. Mutations 
associated with MCDS have, however, also been found in the genomic region 
coding for the N-terminal domain of the type X collagen molecule [lkegawa et al., 
1997], demonstrating the importance of this domain in the formation of the type X 
collagen molecule. 
It was initially suggested that the MCDS phenotype was caused by 
haploinsufficiency demonstrating the nature and distribution of mutations within 
COLlOAl [Warman et al., 1993b; Jacenko et al., 1994]. However, further studies 
by Wallis et al. [1996] which showed a restricted distribution of 21 mutations to 
the carboxyl terminus of COLlOAl, led these authors to conclude that 
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Fig. 2-4. Representation of 6q16.3-q22.3 and the approximate location of the 
microsatellite markers (within 10cM of the candidate region for the COLlOAl gene) 
which were used to show linkage to COLlOAl. This figure incorporates data taken from 
the GDB (http://www.gdb.org). 
2.2.5. Type XI collagen 
Type XI collagen is a structural component of adult articular cartilage, 
constituting about 3% of the type II collagen content [Eyre and Wu, 1995]. The 
type XI collagen triple helix is a heterotrimer containing two unique gene 
products a 1 (XI);a2(XI), and also shares close structural similarities to type V 
collagen. The presence of hybrids containing both type XI and V collagen 
[Kleman et al. , 1992] and the increasing production of type V at the expense of 
type XI during increasing developmental age [Eyre et al., 1987b] suggests that 
the types V and XI are isoforms of each other. Crosslinking studies indicate that 
type XI collagen in the cartilage matrix exists primarily as crosslinked molecules 
within or at the surface of type II collagen fibrils [Eyre and Wu, 1995]. 
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The gene encoding the pro-al(XI) chain, viz. COLI IAI, has been localised to lp21 
[Henry et al., 1988], between the microsatellite markers D1S495 and D1S248 (Fig. 
2-5a), and contains at least 66 exons [Ala-Kokko, personal communication]. The 
COL11A2 gene which was localised to 6p21.3 [Hanson et al., 1989; Kimura et al., 
1989] spans 30.5kb and contains at least 62 exons [Lui et al., 1996]. Microsatellite 
markers within a 2% region around the gene, D1S273, D1S265 and D1S291 [GDB] 
(Fig. 2-5b) were selected for linkage analysis in the present study (Table 2-II). 
Peptide mapping revealed total similarity between a I (II) and a3(XI) chain 
[Burgeson et al., 1982] and it is now known that the a3(XI) chain is a product of the 
COL2Al gene [Richards et al., 1996]. 
Type XI collagen chains copolymerise with types II and IX chains to form the 
cartilage collagen fibrils [Mendler et al., 1989]. It has been suggested that type XI 
collagen molecules limit the size of the collagen fibrils by retaining amino-terminal 
extensions which do not accommodate the addition of type II molecules. An increase 
in the ratio of type XI to type II molecules results in thinner collagen fibrils, and a 
decrease in the ratio results in thicker fibrils. 
The absence of the a 1 (XI) chain in mice with an autosomal recessive 
chondrodysplasia confirms that this molecule is important in skeletal development. 
The COLl lAl mutation in the mouse model results in abnormalities in the cartilage 
of limbs, ribs, mandible and trachea [Li et al., 1995]. The heterozygous mutation 
does not manifest an obvious skeletal phenotype. A genetic defect in COLl lAl has 
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also been shown to be causative of autosomal dominant Stickler syndrome type 2, 
in which both retinal and vitreous abnormalities are present [Richards et al., 
1996]. This mutation involves a Gly-Val substitution in the triple helix and has a 
dominant negative effect by disrupting the function of the other proteins with 
which the abnormal a 1 (XI) chain associates. 
Genetic defects which have been identified in COL11A2 result in AR and AD 
forms of Stickler syndrome type 2 which lack the severe eye abnormalities 
characteristic of the phenotype produced by COL2Al defects [Brunner et al., 
1994; Vikkula et al., 1995]. This is probably due to the a2 (XI) chain in ocular 
tissue being replaced by a2 (V), thus overcoming the effect of the type XI 
abnormality. Further evidence that the a2 (XI) chain is important for skeletal 
development was provided by Vikkula et al. [1995] who found that a Gly-Arg 
substitution in COLI 1A2 caused an AR condition viz. otospondylomega-
epiphyseal dysplasia (OSMED), which is characterised by severe degenerative 
joint disease in early adulthood. 
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Fig. 2-5a. Representation of 1 p 13-p22 and the approximate location of the microsatellite 
markers (within 5cM of the candidate region for the COLI lAl gene) which were used to 
show linkage to COLI lAl. The genetic distances between the markers (shaded) and 
relative to other markers, shown in Kosambi centimorgans (KcM), were obtained from 
the CEPH/Genethon linkage map. This figure incorporates data taken from GDB 
(http://www.gdb.org). 
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Fig. 2-5b. Representation of 6p21.2-p21.3 and the approximate location of the microsatellite 
markers (within 5cM of the candidate region for the COL11A2 gene) which were used to show 
linkage to COL11A2. The genetic distances between the markers (shaded) and relative to other 
markers, shown in Kosambi centimorgans (KcM) were obtained from the CEPH/Genethon 
linkage map. This figure incorporates data taken from GDB (http://www.gdb.org). 
2.3. COLLAGEN BIOSYNTHESIS AND PROCESSING 
Collagen biosynthesis requires co-ordinated transcription of genes which encode 
distinct monomers constituting a single protein. The process relies on multiple 
steps from mRNA translation through posttranslational modifications and 
secretion into the extracellular matrix. 
A collagen molecule is synthesized as a soluble precursor, procollagen, which is 
translated on the free ribosomes of the RER. The procollagen polypeptide chain 
consists of a central helix and terminal globular domains (Fig. 2-6). The globular 
extensions in the procollagen molecule confer solubility and prevent aggregation 
and fibril assembly. The nascent chain undergoes hydroxylation of proline and 
lysine as well as glycosylation of hydroxylysine by enzyme modification within 
the cistemae of the RER. These events begin while the polypeptide chain is 
growing on the 
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Fig. 2-6. A schematic representation of the development of the procollagen molecule 
indicating the intracellular (A) and extracellular (B) processes. The cleavage sites for 
evolution to the mature collagen molecule are indicated. (This drawing adapted from 
Prockop et al. , 1992; Horton and Hecht, 1993) 
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ribosomes but continue in the form of post-translational modification until the 
triple helix formation is complete. 
The triple helix starts forming once the procollagen monomers align themselves 
alongside each other. According to Ahmad et al. [1991], the integrity of the 
carboxyl (C) termini of the procollagen strands is essential for this alignment. The 
association of the C-propeptides of the 3 chains allows a 'nucleus' of triple helix to 
form just beyond the C-propeptide. In the triple helix the three chains are held 
together by a series of water and hydrogen bonds. The helix rapidly propagates in 
a zipper-like fashion from the C-terminus to the amino (N-) terminus. 
Macromolecules mix during packaging in the Golgi apparatus for transport via 
secretory vesicles through the cytoplasm. The triple helical molecule is readily 
secreted via the Golgi apparatus into the extracellular space where the amino (N-) 
and C- termini are cleaved off by specific N- and C- proteinases to form collagen, 
which spontaneously assembles itself into fibrils. 
Fibril formation begins with the structuring of a nucleus by two or more collagen 
monomers. It then rapidly grows by the addition of more monomers to generate a 
large fibril. Every sub-unit of collagen that participates in fibril formation must 
therefore have the correct structure. Self-assembled collagen fibrils are collected 
into bundles and these in turn are organized into tissue specific macroaggregates 
that contain more than one type of collagen. In cartilage the interactions between 
the minor collagens, type IX and XI, with the major collagen component, type II, 
in the same fibril, provides a mechanism for integrating the cartilage network. 
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2.4. MECHANISMS OF COLLAGEN FAILURE 
In both the familial and non-familial forms of OA the degeneration of articular 
cartilage is central to the development of the condition. A number of mechanisms 
can give rise to cartilage destruction; one involves external physical factors which 
place pressure on the joints, thus damaging the cartilage. Another mechanism 
involves the uncontrolled activity of proteases. Fibrillar collagens are usually 
stable for months or years in adult tissue and their turnover, which is triggered by 
injury or stress, is regulated partly by collagenases which recognise specific 
cleavage sites in the triple helix [Byers, 1993]. This process renders the helix 
susceptible to less specific proteases which can degrade the molecule further. In 
normal cartilage regulatory mechanisms govern the balance between the 
production of collagen and proteoglycan molecules, and their degradation by 
naturally occuring proteases. It has been hypothesized that a loss of these 
regulatory mechanisms could result in uncontrolled action of the proteases leading 
to the destruction of the cartilage matrix [Horton and Hecht, 1993]. A third 
mechanism involves internal factors such as mutations in genes which encode 
cartilage matrix components. The latter results in the incorporation of defective 
proteins during cartilage biosynthesis, which destabilises the cartilage matrix. 
Alternatively, defective proteins may result in haploinsufficiency, which is a 
reduction of the number of monomers available for triple helix formation and, 
thereby, a reduction in the total collagen content. 
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Prockop et al. [1992] devised experiments to determine the mechanisms by which 
mutations can alter the biological function of a collagen molecule. Their findings 
are listed below and are depicted schematically in Fig. 2.7: 
(i) procollagen suicide - the C-terminus of the procollagen chain is essential 
for association and self assembly into collagen fibrils . However, if the C-
terminus is intact but a mutation disrupts the triple helical domain of the 
chain, the triple helix will not be formed. The three strands will thus 
remain unfolded and will be degraded or secreted. In this instance some of 
the normal collagen chains will also be degraded since they will not be 
incorporated into triple helices. 
(ii) persistence of the N-propeptide - if a mutation in the region of the N-
propeptide prevents cleavage by the N-proteinase, the self-assembly of the 
collagen chains into fibrils will be either partially or completely inhibited. 
(iii) base substitutions - a single-base mutation resulting in a Gly substitution 
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Fig. 2.7. Mechanisms of collagen failure [adapted from Prockop et al., 1992]. The drawing 
shows the effect of a mutation on the collagen triple helix. The mutation can either (a) result 
in "procollagen suicide" by inhibiting the folding of the triple helix. This results in 
degradation of the procollagen monomers or (b) the structurally abnormal monomer can be 
incorporated into the triple helix and thus result in abnormal collagen fibrils. 
2.5. NON-COLLAGENOUS COMPONENTS OF ARTICULAR 
CARTILAGE 
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The non-collagenous extracellular matrix components which are all important in 
ensuring the normal functioning of articular cartilage include the large proteoglycan 
core protein, aggrecan, and the smaller proteoglycans such as decorin, fibromodulin 
and lumican. Other proteins included in this category are the cartilage link protein, 
cartilage oligomeric matrix protein, cartilage matrix protein (also known as matrilin) 
the chondrocalcinosis gene (CCAL2) product, and stromelysin/matrix 
metalloproteinase-3. 
Proteoglycans are macromolecules which comprise a core protein to which a number 
of glycosaminoglycans (GAGs) are covalently bound. The GAGs are made up of a 
disaccharide repeat unit which consists of a uronic acid and a hexosamine; more than 
one type of GAG may be attached to the core protein. Proteoglycans appear to 
perform complex, but vital functions which are determined by the core protein or by 
the GAG chains. Through their length, the GAGs impart a high viscosity and shock 
absorbance to solutions, and are thus ideal lubricants in the articulating joints of the 
body. 
2.5.1. Aggrecan 
The GAG chains of aggrecan impart an osmotic pressure effect which is an 
important component of the total swelling pressure of articular cartilage. One of the 
main functions of aggrecan is its resistance to compression of tissue and its 
interaction with certain collagen molecules to stabilize the cartilage matrix. 
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The aggrecan gene, AGCl, has been localised to 15q26 [Korenberg et al., 1993] 
and is encompassed by the microsatellite markers, D15S130 and D15S202 [The 
Human Gene Map] (Table 2-II). An intragenic VNTR has been identified within 
the chondroitin-sulfate attachment domain of the gene [Doege et al., 1997], and 
was used for linkage analysis in the present study. A defect in AGCl has been 
identified in murine AR chondrodystrophy (cartilage matrix deficiency) [Kimata 
et al., 1981; Watanabe et al., 1994, 1997]. Mice which were heterozygous for the 
mutation were slightly dwarfed and had vertebral abnormalities. A mutant chicken 
phenotype "nanomelia" has been found with the AGCl gene [Primorac et al., 
1994]. 
2.5.2. Cartilage link protein (CRTLl) 
Stabilization of the cartilage matrix is attributable to the proteoglycan link protein 
(CRTLl) which is thought to bind to aggrecan and function in the early formation 
of proteoglycan aggregates with hyaluronic acid [Hardingham, 1979]. 
The CRTLl gene which has been mapped to 5ql3-14 [Osborne-Lawrence et al., 
1990] has 5 exons and spans about 60kb [Dudhia et al., 1994]. A polymorphic 
dinucleotide repeat was used as the intragenic marker for linkage analysis in the 
present study. To date, the gene has not been implicated in the causation of human 
chondrodysplasias. 
33 
2.5.3. Cartilage oligomeric matrix protein (COMP) 
COMP is a member of the pentameric thrombospondin protein family and is 
thought to have a calcium-binding function in the extracellular matrix. The COMP 
gene was localised to 19p12-13 and has 19 exons [Briggs et al. , 1994; Newton et 
al., 1994 ]. The locus is flanked by the microsatellite markers, D19S49 and 
D19S253. Closely linked markers, D19S602, D19S212 and D19S215, were 
selected for the present candidate screening (Fig. 2-8). 
Genetic defects in the calmodulin-like repeat domain of the COMP molecule may 
cause either MED [Briggs et al., 1995; Ballo et al., 1997] or pseudoachondroplasia 
(PSACH) [Hecht et al., 1995]. Most of the mutations involve aspartic acid 
residues which are thought to be essential for the calcium-binding function of the 
COMP molecule. Other mutations include substitutions of conserved cysteine 
residues in the calmodulin-like repeat region. The large-scale reduction of normal 
pentameric molecules in the presence of a mutated COMP monomer, suggests that 
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Fig. 2-8. Representation of 19p 12-p 13 and the approximate location of the microsatellite markers 
(within 5cM of the candidate region for the COMP gene) which were used to show linkage to 
COMP. The genetic distances between the markers (shaded) and relative to other markers, are 




Decorin is a small proteoglycan found in almost all connective tissues. The 
molecule decorates the collagen fibres, increasing the surface for interfibre 
interaction. The proteoglycan molecules are also thought to immobilize growth 
factors which they release during self-degradation and thus may play an active 
role in cartilage repair. 
The DCN gene which was localised to 12q21-22 [McBride et al., 1990; Pulkkinen 
et al. , 1992] between the microsatellite markers, D12S322 and D12S346 [The 
Human Gene Map], is larger than 38kb and contains 8 exons [Danielson et al., 
1993]. Little is known about the involvement of DCN in the aetiology of 
chondrodysplasias. 
2.5.5. Fibromodulin 
Fibromodulin is a small proteoglycan which contains a core protein that is 
structurally related to decorin. Experimental evidence of the molecule's ability to 
bind type II collagen and inhibit fibril assembly, suggested that fibromodulin may 
participate in extracellular matrix assembly [Ayad et al., 1994]. 
The gene encoding fibromodulin, FMOD, is about 8.5kb in length and has been 
localised to lq32 [Sztrolovics et al., 1994] between D1S1660 and D1S1678 [The 
Human Gene Map]. These markers along with a marker located between them, 
D1S306 (Fig. 2-9), were used for linkage studies. The role of the gene in the 
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Fig. 2-9. Representation of lq31-q32 and the approximate location of the rnicrosatellite markers (within 
10cM of the candidate region for the FMOD gene) which were used to show linkage to FMOD. This 
figure incorporates data taken from the GDB (http://www.gdb.org). 
2.5.6. Chondrocalcinosis locus on Sq (CCAL2) 
A locus on 8q has been shown to be associated with severe degenerative OA of 
early onset in a large family [Baldwin et al., 1995]. The condition is characterised 
by the deposition of calcium-containing crystals in joint tissue. Affected 
individuals experience bouts of acute inflammatory arthritis which is triggered by 
trauma, exercise or weather fluctuations. Genetic linkage results in this kindred 
suggest that there may be a defective gene (CCAL2) on the long arm of 
chromosome 8 between the microsatellite markers D8S525 and D8S284 (Fig. 2-
10). Although the exact function of CCAL2 is unknown, its linkage to an early-
onset form of OA suggested that it may be a suitable candidate for Mseleni joint 
disease. Microsatellite markers located between the flanking markers were used in 






Bq22.3 DBS546 116.0 
DBS556 117 .0 
- DBS521 118.0 
Bq23 .1 119.0 
Bq23.2 120.0 
Bq23.3 
DBS281 121 .0 t,)8s5sgj- 122.0 
DBS53Q I DBS565 DBS547 123.0 Bq24.11 DBS555 
DBS522 
Fig. 2-10. Representation of 8q22-q24 and the approximate location of the microsatellite 
markers (within 5cM of the candidate region for the CCAL2 gene) which were used to 
show linkage to CCAL2. The genetic distances between the arkers (shaded) and 
relative to other markers, are shown in Kosambi centimorgans (KcM). This figure 
incorporates data taken from the GDB (http://www.gdb.org). 
2.5.7. Lumican 
Lumican is a small, leucine-rich proteoglycan that is present in many tissues, 
including articular cartilage [Grover et al., 1995]. Similarly to the other small 
proteoglycans, decorin and fibromodulin, the expression is higher in adults than in 
juveniles. 
The lumican gene, LUM, is located on chromosome 12q22 and spans a 7.5kb 
genomic region. Microsatellite markers within 5cM of the gene were used for 
linkage studies (Fig. 2-11) [Chakravarti et al., 1995]. The 3-exon gene is situated 
close to the DCN locus. 
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Fig. 2-11. Representation of 12q21.2-q22 and the approximate location of the 
microsatellite markers (within 5 cM of the candidate region for the LUM gene) which 
were used to show linkage to LUM. The genetic distances between the markers (shaded) 
and relative to other markers, are shown in Kosambi centimorgans (KcM). This figure 
incorporates data taken from the GDB (http://www.gdb.org). 
2.5.8. Cartilage matrix protein (CRTM) 
Cartilage matrix protein is a major component of the extracellular matrix protein 
of non-articular cartilage. The exact function of the gene, CRTMIMATNl, 
encoding this protein is not known, but recent investigations suggest that the 
CRTM locus may play a role in the sex- and joint site-specific pattern of 
radiologically evident OA [Meulenbelt et al., 1997]. Moreover, Okimura et al. 
[1997] demonstrated that articular chondrocytes can synthesize CRTM, although 
the synthesis is suppressed under physiologic conditions. Their results also 
suggest that articular chondrocytes express the protein in response to arthritic 
stimuli. In light of these reports, CRTM was included as a candidate in the South 
African study as it may well be found to play a contributory role in familial OA 
disorders. 
The CRTM gene which spans a 12kb region on lp35 [Kiss et al., 1989; Jenkins et 
al., 1990] has eight exons. A polymorphic VNTR has been isolated from the 
region [Wang et al., 1992] and was used in the present study. 
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2.5.9. Stromelysin/matrix metalloproteinase 3 
Stromelysin is a proteoglycanase which is closely related to collagenase and is 
identical to metalloproteinase 3 (MMP3) [Wilhelm et al., 1987; Saus et al., 1988]. 
The gene has been localised to 1 lq22-q23 [Formstone et al., 1993]; the translation 
product is produced predominantly by connective tissue cells and is capable of 
degrading components of the extracellular matrix [Sellers and Murphy, 1981]. 
The microsatellite marker, Dl 1S898, which is located within 5cM of the 
candidate region for MMP3 [GOB] was used to investigate linkage to the gene in 
the present study (Fig. 2-12). 
Stromelysin has a high affinity for cleaving type IX collagen molecules as well as 
cleaving telopeptides from type II collagen, and it has the potential to degrade the 
connections between type II and type IX fibrils. It is therefore possible, as 
mentioned earlier, that if the regulatory mechanisms governing the action of these 
proteases are lost in a disease state such as OA, their uncontrolled action could 
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Fig. 2-12. Representation of 1 lq22-q23 and the approximate location of DI 1S898 
(within 5cM of the candidate region for the MMP3 gene) which were used to show 
linkage to MMP3. This figure incorporates data taken from the GDB 
(http://www.gdb.org). 
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Table 2-I. The candidate genes, their chromosomal locations and the intragenic and 
closely linked microsatellite markers which were used for genotype analysis. The 
Genome Data Base is referred to as GDB and the CEPH/Genethon linkage map as 
CGM. 
GENE LOCUS MARKERS REFERENCE 
COL2Al 12q 13.11-12 Dl2S361 GDB 
Dl2S368 GDB 
VNTR Stoker et al., 1985 
COL6A2 21q22.3 [Ca]n Comeglio et al., 1996 
COL6A3 2q37 D2S345 GDB 
D2S338 GDB 
COL9Al 6ql2-13 50912Bl Warman et al., 1993 
509-8B2 " 
COL9A2 lp32.3-33 MYCLl Hellsten et al., 1995 
COL9A3 20ql3.3 D20S171 Brewton et al., 1995 
D20S64 CGM 
COLIOAl 6q22.3 VNTR GDB 
D6S474 GDB 
D6S1639 GDB 









AGCl 15q26 VNTR Doege et al., 1997 
CRTLl 5q13-14.1 VNTR Hecht et al., 1991 
COMP 19pericentro- D19S212 Hecht et al., 1993 
menc region D19S215 Briggs et al., l 993(b) 
D19S602 
DCN 12q21-22 VNTR Briggs et al., 1993(a) 
D1S306 CGM 
FMOD lq32 D1S1660 GOB 
D1S1678 GOB 
D12Sl01 GOB 
LUM 12q22 D12S1064 GOB 
CRTM lp35 VNTR Wang et al., 1992 
MMP3 llq22-23 Dl 1S898 GOB 
D8S539 Baldwin et al., 1995 
CCAL2 8q D8S565 " 
D8S269 " 
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CHAPTER 3: 
A STICKLER-LIKE SYNDROME 
3.1. INTRODUCTORY BACKGROUND 
Stickler syndrome is a clinically and genetically heterogeneous group of autosomal 
dominant disorders. The classical phenotype of the Stickler syndrome is high myopia 
with a vitreous anomaly plus a high frequency of retinal detachment and cataracts. 
Hearing loss and skeletal involvement are variable and may be absent in some affected 
persons [Zlotogora et al., 1992]. The clinical manifestations vary between families but 
show little intra-familial variability. Secondary degenerative arthropathy, presumably 
consequent upon epiphyseal involvement, is a feature in some affected kindreds. 
Different forms of the Stickler syndrome are reported to be distinguishable clinically by 
the presence of a vitreo-retinal component. In this regard, Snead et al. (1994) suggested 
that the condition can be subcategorised into type 1, in which ocular abnormalities 
predominate, and type 2, in which eye changes are different or absent. This concept is 
not, however, universally accepted. In any event, it is likely, that there is even greater 
heterogeneity. 
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Stickler syndrome type 1 has thus far been found to be associated with the COL2Al 
gene which encodes type II collagen [Snead et al., 1994]. In all affected persons 
investigated, the causative gene defect has been shown to be a termination signal leading 
to premature truncation of type II procollagen chains. Seven of the 9 mutations 
described in affected individuals have been single base changes (Table 3-l) resulting in 
premature stop codons and truncated polypeptide chains which impair the assembly of 
the procollagen triple helix [Ahmad et al., 1991, 1993, 1995; Brown et al., 1992, 1995; 
Ritvaniemi et al., 1993]. Either an in-frame stop codon is created or the reading frame is 
shifted so that an out-of-frame stop codon is encountered downstream. The resultant 
polypeptide chains are truncated and lack the noncollagenous carboxy -propeptide which 
is necessary for incorporation into triple-helical molecules. It is predicted that type II 
collagen triple helices are reduced in the cartilage matrix (haploinsufficiency) which can 
therefore not function properly as a template for endochondral ossification [Horton, 
1995]. In Stickler syndrome the type II collagen defect manifests in the eye since the 
protein is a major component of the vitreous humour. The reduction in type II collagen 
possibly results in an abnormality of the interface between the retina and the vitreous 
jelly, resulting in the retinal detachments seen in Stickler syndrome. 
The other reported mutations involve a 1 Obp insertion [Brown et al., 1995] and a 16bp 
deletion [Williams et al., 1996] which result in termination signals further downstream 
and consequently truncated peptides. In Stickler syndrome type 2, ocular involvement is 
either different from that in type 1, or entirely absent [Snead et al., 1994]. To date, this 
form of the disorder has not been linked to COL2A 1, but the phenotypes in two large 
families have been associated with COLl lAl [Richards et al., 1996] and COL11A2 
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[Brunner et al., 1994]. There are, however, some kindreds in which the disorder has not 
been linked to either the COL2Al or COLl 1 loci, thereby demonstrating additional non-
allelic heterogeneity [Knowlton et al., 1989; Vintiner et al., 1991; Bonaventure et al., 
1992]. 
In the present study, a South African family of Afrikaner stock, with early onset myopia, 
conductive deafness and generalised epiphyseal dysplasia was investigated for a 
molecular defect. The affected relatives were initially described by Beighton et al. 
[1978] and reviewed again in 1994. At this time, and with informed 
Table 3-I. Termination mutations in the COL2Al gene which result in Stickler type 1 
syndrome. 
EXON MUTATION POSITION OF STOP CODON REFERENCE 
40 1 hp substitution Arg 732 Ahmad et al., 1991 
40 1 hp deletion Exon42 Brown et al., 1992 
7 1 hp substitution Arg9 Ahmad et al., 1993 
43 1 hp deletion Exon44 Ritvaniemi et al, 1993 
4 1 Obp insertion Exon5 Brown et al., 1995 
20 1 hp deletion Exon 26 Brown et al., 1995 
48 1 hp insertion Exon 51 Brown et al., 1995 
50 1 bp deletion Exon 51 Ahmad et al., 1995 
18 16 hp deletion Williams et al., 1996 
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consent, venous blood specimens were obtained for the molecular studies which form 
the subject of this chapter. These molecular findings have been published in an article 
entitled "A Stickler-like syndrome due to a dominant negative mutation in the COL2Al 
gene" [Balla et al., 1998]. 
3.2. METHODS AND MATERIALS 
(i) The Family 
The affected family belongs to the Afrikaans-speaking Caucasian community of South 
Africa. Family members were ascertained in 1978 when three affected sibs were 
encountered during diagnostic surveys in special schools for the deaf in the city of 
Pretoria, South Africa. Detailed otological, ophthalmological and radiographic studies 
showed that these children had myopia, bilateral conductive deafness, a round flattened 
facies and mild generalised epiphyseal changes. Crenated cataracts and asteroid hyalosis 
of the vitreous were variable manifestations in the affected individuals. The condition 
was regarded as a form of multiple epiphyseal dysplasia (MED) and in particular, the 
joint changes and stubbiness of the digits were in keeping with this diagnosis. The 
clinical and radiographic features of the affected persons are depicted in Fig. 3-1 and 
Fig. 3-2a. Their mother was similarly affected, but another brother, and the mother's 
parents and sibs were normal. Pattern profile analysis using the method developed by 
Poznanski et al. [1972], was undertaken to determine the extent of digital shortening 
(Fig.3-2b ). At the clinical level, the unaffected family members did not have stunted 
digits. 
Fig.3-1. The clinical features of the affected kindred. The affected mother and her three 
affected offspring who all have high myopia, stubby digits and a round flat face. (From 
Beighton et al., 1978. Reprinted by permission of the editor of Clin Genet). 
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Fig. 3-2(a) Stickler-like kindred: Anterior-posterior radiograph of the hands of an affected 
child, showing the short phalanges. 
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Fig.3-2(b). Stickler-like kindred: Pattern profile analysis of the digits of the proband age 33 
(M33) and two affected children aged 6 (F6) and 7 yrs (M7). Shortness of all the tubular 





(ii) Molecular Genetic Investigations 
Linkage Analysis 
Peripheral venous blood (10ml) was obtained by venipuncture. Genomic DNA 
from family members was extracted using the Genomix ™ blood scale-up kit 
[Talent, Italy](see Appendix 1, section 1.1.). The COL2Al chromosomal region, 
12q13.l 1 - 12q13.12 [Takahashi et al., 1990], was genotyped using primers for 
the COL2Al 3' VNTR [Stoker et al., 1985] and the microsatellite markers, 
D12S368, D12S361 and D12S339 [Research Genetics, USA]. The localisation of 
these markers on chromosome 12 is given in Ch.2, section 2.2.1. In addition, 
markers closely linked to the MED candidate loci, EDMl/COMP (D19S215 and 
D19S212 - see Ch.2, section 2.5.3.) [Briggs et al., 1995] and EDM2/COL9A2 
(MYCLl - see Ch.2, section 2.2.3.) [Warman et al., 1994; Hellsten et al., 1995] 
which were commercially available [Research Genetics, USA], were also tested. 
The PCR reactions were performed with 100-200ng of genomic DNA as 
templates; 5-1 Opmol of each primer; 1 µCi of a-[32P]dCTP; 200µM dA TP, dCTP, 
dGTP and dTTP; and 0.5U of Taq polymerase [ GibcoBRL, UK], in a final volume 
of 1 Oµl. Samples were cycled 25 times in a Omnigene [Hybaid, UK] PCR 
machine using annealing temperatures of 60°C (COL2Al VNTR) or 55 °C 
(microsatellite markers). PCR products were checked for size by comparison with 
a 1kb molecular weight marker [GibcoBRL, UK] on 2% agarose [Sigma, USA] 
gels. Ten µl of formamide loading buffer (Appendix 1, section 2.1.2.) was added 
to each reaction after PCR. The samples were denatured for 3 minutes at 95°C and 
chilled on ice for 10mins, followed 
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by electrophoresis through 6% denaturing polyacrylamide gels (see Appendix 1, 
section 2.1.3). The gels were dried onto 3MM paper [Schleicher and Schue/I, 
Germany] on a slab gel drier [Hoefer Scientific Instruments, USA] for l-2hrs at 80°C 
and exposed to X-ray film [Agfa, Germany] for 16-32hrs at -70°C. The 
autoradiographs were developed and the alleles scored for the rnicrosatellite markers. 
Linkage analyses were performed usmg the LINKAGE package Version 5.03 
[Lathrop and Lalouel, 1984] and the map order from the Genethon map of 
microsatellite markers for each chromosome. In all analyses the number of alleles for 
each marker was reduced to five, without loss of information in the family, in order to 
accommodate the computer program's limitations for numbers of alleles. Male and 
female recombination rates were taken to be equal. The condition was assumed to be 
autosomal dominant with full penetrance and a gene frequency of 0.001 was assumed 
for the disease locus. 
Mutation Analysis 
Once the determinant gene had been identified using the linked microsatellite 
markers, the exons of the gene were screened for small mutations using SSCP 
analysis (see Appendix 1, section 2.2.1). Genomic DNA was extracted from blood 
samples and the exons and flanking sequences of the triple helical domain were 
amplified by a series of intronic primers (Table 3-Il). The PCR was performed in a 
total volume of 25µ1 using primer-specific annealing temperatures (Table 3-Il). PCR 
products were checked for size by comparison with a 1kb molecular weight marker 
[GibcoBRL, UK] on 2% agarose [Sigma, USA] gels. Formamide loading buffer (see 
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Appendix 1, section 2.2.1.2.) was added to each reaction in a 1: 1 dilution, the samples 
denatured for 2 mins at 95°C and then chilled on ice for 5mins to allow the single 
stranded DNA to reanneal. Ten µl of the sample was electrophoresed through a non-
denaturing 0.5 x MDE™ gel matrix [FMC BioProducts, USA] at 5-IOW for 18 hrs 
followed by silver staining to visualize the DNA banding patterns [Lohmann et al., 
1992]. The methods were as decribed in Appendix 1 (section 2.2.1.2). 
Following the observation of SSCPs, the relevant exon was sequenced in order to 
determine the nucleotide changes which resulted in the bandshifts. The double-
stranded PCR products were purified using the QIAquick protocol for eluting DNA 
from a gel matrix [Qiagen, Germany] and sequenced, in the 5' and 3' directions, 
using the Sequenase version 2.0 DNA sequencing kit [United States Biochemical 
(USB), USA] (see Appendix 1, section 2.2.2). Sequencing reactions were analysed on 
6% PAGE gels, dried at 80°C and visualised by autoradiography. 
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Table 3-II. Oligonucleotide sequences of primers used to amplify the exons of the 
triple helix of the COL2Al gene. 
Exon PCR Primer sequence PCRproduct Annealing 
(bp) temperature 
(OC) 
6 5'-GTGCCTTTCAACCTCCT AACG-3' 157 57 
5'-CCTGCCATTTTGGCTGCAAAG-3' 
7/8 5'-GCATGTGTAGT AAACCCCTC-3' 272 55 
5'-GGACAGGGCCGTGCTGGT AC-3' 
9 5'-CT AT AACCATCTCTT AAACT ATC-3' 131 55 
5'-AGGAGGCAGCTCCTCATTTG-3' 
10 5'-GTCTCTGAGGAAGCTGGGATA-3' 132 59 
5'-CTAGGAAAGATGCCTGAGGCT-3' 
11 5 '-CTCTGTGCTCTGAACACCTCC-3' 128 57 
5'-GGCATCTCTTCCTTCCAACC-3' 
12 5'-GT AAGTATCACGGGTGAGAAG-3' 282 57 
5'-GCTAGTTCCACTGAGCTCCAC-3' 
13 5'-GTGGAGCTCAGTGGAACTAGC-3' 312 60 
5'-GAGTCTTTGAT AAACCTTCCTGG-3' 
14 5'-AGCCAACTCATGCTTAGGCTG-3' 124 59 
5'-AA TGGTGGTGTTTGGCTTTGTC-3' 
15 5'-CTGTGGGCACCTCTCATGG-3' 124 57 
5'-GCACAGCAACAA TGACCTGCT-3' 
16 5'-CTGGCATTCACCTCTCTTCTC-3' 131 55 
5'-GCACCCAGAAGTTCCTGACTG-3' 
17 5'-CTTCATTTCATACCTCCCTGTC-3' 156 59 
5'-CCCAGGCCAAAGAGAAGCTG-3' 
18 5'-GCTGCTT A TTTGACAA TGTCTC-3' 114 57 
5'-GGCTCTCCTGGGGTAGCAAAG-3' 
19 5'- CTGTGAGTGTTGCCCGTGGAC -3' 325 60 
(* l ) 5'- CCAGAACCCCTGTTCAAGATG-3' 
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20 5'-GGAGAGAA TCTGGTGTGAGG-3' 132 57 
5'-CAGCAGCAGAGAAGACAAGG-3' 
21 5'-GTGAAGGCTCACTCTGTTTC-3' 178 56 
5'-CCATGGGATGGAGCCTCCAC-3' 
22 5'-CTGTTCTCACTCACTGCCTC-3' 57 
5'-AGAGAAGAGGGTGGGGTCAG-3' 
23 5'-CTGACTCCCTGTGTACCCTTG-3' 248 55 
5'-AGAGAAGAGGGTGGGGTCAG-3' 
24 5'-CAGCCCTGCACTGCCAGGAT-3' 160 60 
5'-CCCTCCTAGCAGCCCTCAGC-3' 
25 5'-GTGTCTATGTTCTGAGAA TGGTG-3' 174 59 
5'-CACCACATGGAAGGAAATAGAAG3' 
26 5'-AACCATCCGCCTCATGGCC-3' 57 
5' -GGCCAACACCAAGTCATGGG-3' 
27/28 5'-AAGCGTGTCATTGGACTTTTCTT-3' 692 55 
5'-TGGCCCCCAGGGCCACCTG-3 
29 5 ' - GTCTGCCCT ATACTGTGCCTC -3' 217 61 
(*I) 5 ' - ATGCCCTCTTGCCCTTGCCTC -3 
30/31 5 '-TCTGTGAT A TGAAGCCTTCACTC-3' 358 61 
(*2) 5 '-ACTGGATGCAGCCTCACTT A-3' 
32 5'- GGAGCTGGAAAGGAGGTCTCA -3' 329 61 
5'-GGTGCCATAAGGGAACGGAAG-3' 
33 5'-GTGCCCGGCTGAGGCGGCTG-3' 130 55 
5'-TCCT AA TGCCCAGCAGTCCAG-3' 
34 5'-CTCAGCCTGCCTCCCTCACC-3' 133 55 
5'-GGGAGGCAAGGTGTGGAGAG-3' -
35 5'-ACCTTCTT ACCCCAGCTCTTC-3' 134 60 
5'-GGCCTCGGGCAGAGCCAGGC-3' 
36 5'-CAGCGGGGCCTGACTCTCGC -3' 134 56 
5'-CTGAGTGGAGGTACCCAGGAG-3' 
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37 5'-CACCTGCTTCCTCCTTCCCCA-3' 161 
5'-AA TTCTTGGAGTGCAGCGTTAC-3' 
38 5'-GCCACTGGGCCTCACTGTC-3' 131 
5'-TTTGTGAGGTGCAGGGTGGG-3' 
39 5'-AGGGCTTGAGGTTCTCAGGG-3' 134 
5'-CATGCCTGCCTGTGCCTCTC-3' 
40 5'-GGTGAGATGAGTCCTCACTTC-3' 227 
5'-GGCATGGGCCTGGTGAGGG-3' 
41 5'-GGCCACTGTCAGTTCTCATCTC-3' 188 
5'-AGGGCCAGCTTGGATGGAGG-3' 
42 5'-CACTCATCATCCTTGTCTCTGTC-3' 177 
5'-CTCCCCAA TCAGGGCCACCC-3' 
43 5'-GGAAGCAGCTCT AAGTGCATTC-3' 123 
5'-CACTGCACACACAGACACCAG-3' 
44 5'-GGAACATTCTTCTCTGAGCCTG-3' 188 
5'-GACGTTGT AAAACGACGGCCAG-3' 
45 5'-TCCTGGCTTTTCTCTGACGCTG-3' 134 
5'-TCCCTGGTGGGGACTCAGTG-3' 
46 5'-CCCTGACCTGACTCAA TCGG-3' 185 
5'-AGGAGGCCTCGGGAAGTCCC-3' 
47 5'-GCTGACCGTGGCCTTTTGCC-3' 127 
5'-AAGGGCCCCCTCCATCTTCC-3' 
48 5'-CCAACTTAGGGTTCCATGACTG-3' 291 
5'-GGGACACCTCGACAGCAGGG-3' 
49 5'-CACACAA TCCTGGCTGATCTC-3' 366 
5'-CCTGCTTCCCGGGGCAGG-3' 
NOTE- For each exon the forward or sense primer is given on the top line and the reverse 
(antisense) primer is given below. DNA was amplified under the following PCR conditions: 
denaturation at 94°C for 30 secs, annealing temperature as tabulated and extension at 72°C 
for 30 secs. Primer sets marked with • 1 were obtained from Dr Jarmo Korkko, PA, USA. 
Primer sets marked with •2 were were designed in the UCT laboratory. The remaining 















3.3. RES UL TS 
The pedigree of the portion of the family which was available for investigation is 
shown in Fig. 3-3(a). DNA from individuals 1-1, 1-2, 11-1 , 11-2, 11-3, and 11-4 was 
available for linkage analysis. Recombinant meioses, detected with the markers 
D19S215 and MYCLl, led to the exclusion of COMP and COL9A2. Taking into 
account the size of the available family, the lack of recombination and LOD 
scores of 0.90 (D12S361), 0.90 (D12S339) and 0.86 (D12S368) at theta=0.00 
provided evidence against the exclusion of the candidate gene, COL2Al, and led 
to its further investigation. 
A conformational polymorphism in an amplified DNA fragment containing exon 
39 of the COL2Al gene consistently cosegregated with the condition in the family 
(Fig. 3-3b). Neither the unaffected family members nor 54 normal random 
controls from the South African Afrikaner population, exhibited a variant SSCP 
pattern. DNA sequencing revealed a C2503T transition (Fig. 3-4), implying the 
substitution of a basic arginine by an uncharged cysteine residue at position 704 
of the type II collagen molecule. 
3.4. DISCUSSION 
The South African family in this study has a condition which resembles Stickler 
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Fig.3-3 . Stickler-like kindred: (a) Pedigree and (b) PCR-SSCP analysis of exon 39 of the 
COL2A I gene in a South African kindred with a phenotype resembling Stickler type 1 
syndrome. Shaded symbols on the pedigree represent affected individuals. The SSCP 
change cosegregates with the disorder. 
a. 
nt position 2503 
GGA GCT GCT GGC CGC GTT GGA 
Gly Ala Ala Gly Arg Val Gly 
aa position 704 
GGA GCT GCT GGC TGC GIT GGA 
Gly Ala Ala Gly Cys Val Gly 
b. 





Fig. 3-4. Sequence analysis of nonnal and mutant PCR-amplified genomic DNA. (a) 
Partial sequence of COL2Al exon 39. The nonnal and abnonnal alleles are shown. (b) 
Results of sequence analysis. The sequencing gel showing the region of exon 39 of the 
COL2A 1 gene in which the base substitution occurs. The arrow indicates the C-T 
transition at nucleotide (nt) position 2503. 
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individuals were initially described and depicted in an article entitled "Dominant 
inheritance of multiple epiphyseal dysplasia, myopia and deafness" [Beighton et 
al., 1978]. The phenotype, however, closely resembled that of Stickler syndrome 
type 1 and the issue of diagnostic categorisation remained a matter of concern. 
The nature of the COL2Al mutation identified in this kindred, i.e. the arginine to 
cysteine conversion, has previously been associated with a spectrum of 
spondyloepiphyseal dysplasia (SED) phenotypes {Table 3-III), whereas Stickler 
type 1 syndrome has only been associated with termination mutations. In order to 
make an accurate classification of the clinical phenotype in this kindred, it may 
therefore be necessary to take into account the broad spectrum of type II 
collagenopathies which can be caused by a defective COL2Al gene. 
The term SED is applied in the broad sense to any chondrodysplasia in which the 
vertebral bodies and the epiphyses of the long bones are primarily involved. In 
accordance with this definition, Stickler syndrome can be included in this wide 
category. In the narrow sense, classical SED is conventionally subdivided into the 
autosomal dominant SED congenita [SEDC] and the X-linked tarda [SEDT] 
forms, both of which have specific clinical and radiographic phenotypes. 
However, there is considerable variability and several other forms of SED have 
been delineated, the phenotypic spectrum ranging from severe dwarfing dysplasias 
with facial, ocular and auditory abnormalities through to mild epiphyseal 
dysplasias with premature osteoarthritis [Cole et al., 1994]. 
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The condition in the South African family described in this study resembles that 
of the family described by MacDermot [1987], the main features of both 
conditions being myopia and sensorineural deafness. Although the 'MacDermot' 
phenotype resembled both Stickler type 1 syndrome and SED congenita (SEDC), 
it was considered to be a distinct entity. With regard to the brachydactyly 
component, the only other report of SED with brachydactyly, concerned a family 
from the Chiloe islands off the southwest coast of South America, who had a form 
of SED Tarda (SEDT); their other features included precocious OA and intra-
articular calcification [Reginato et al., 1994]. The affected Chiloan islanders had 
no ocular abnormalities while their severe skeletal problems necessitated hip 
replacements; conversely, skeletal involvement in the South African kindred was 
of a relatively minor degree. 
The gene encoding type II collagen, COL2Al, has been implicated in a number of 
disorders in the general SED category, including some, but not all, instances of the 
Stickler syndrome. There is further semantic complexity as COL2Al has been 
found to be involved in "mild chondrodysplasia with osteoarthritis" [Bleasel et al. , 
1995] and "SED and precocious osteoarthritis" [Williams et al., 1993]. These 
disorders are not autonomous entities as degenerative osteoarthropathy can be a 
complication of virtually any form of SED. Type II collagen has been shown to be 
defective in some instances of Stickler syndrome type 1 [Snead et al., 1994] 
which is typically characterised by severe ocular abnormalities with other 
manifestations such as hearing loss and epiphyseal dysplasia. The condition is, 
however, clinically and 
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Table 3-III. Chondrodysplasia-causing Arg-Cys mutations which have been identified 
in the type II collagen triple helix. 
POSITION 
LOCATION IN GLY-X-Y PHENOTYPE REFERENCE 
EXON 
SED with precocious OA Williams et al., 1993 
Arg75-Cys 11 Gly-Ala-Arg 
No ocular abnormality Reginato et al, 1994 
Precocious OA with mild Ala-Kokko et al., 1990 
Arg519 - Cys 31 Gly-Pro-Arg chondrodysplasia Eyre et al., 1991 
No ocular abnormality Holderbaum et al., 
1993 
Williams et al., 1995b 
Arg789 - Cys 41 Gly-Gln-Arg SED congenita Chan et al., 1993a 
Variable myopia 
Arg704 - Cys 39 Gly-Arg-Val Stickler-like syndrome Present study, 
Myopia and deafness Ballo et al., 1998 
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genetically heterogeneous and there is considerable controversy concerning the 
syndromic boundaries and nosology of the Stickler syndrome. The South African 
family reported in this study has a phenotype which is compatible, to some extent, 
with the Stickler syndrome although the digital shortening in the affected persons is 
not in keeping with this diagnosis. 
The COL2A 1 mutations thus far described in individuals affected with Stickler 
syndrome type 1, have been mostly single base changes. All of the COL2A 1 
mutations causing the disorder result in premature stop codons and truncated 
polypeptide chains which lack a carboxyl terminus [Ahmad et al., 1991, 1995; 
Brown et al., 1992, 1995; Ritvaniemi et al., 1993]. Since this domain is essential for 
the initiation and propagation of the type II collagen triple helix, it is likely that the 
defective chains are not selected for assembly of the trimeric molecule [Ahmad et al., 
1991]. It was previously postulated that a mutation which does not allow an abnormal 
molecule to be incorporated, or one that reduces the amount of collagen chain 
monomer available for incorporation (haploinsufficiency), would be expected to have 
mild consequences [Sykes et al., 1983]. Thus, in Stickler syndrome type 1, because 
the carboxyl-deficient procollagen chains would not be included in the triple helix, 
their interference during fibril formation would be minimal. 
In the South African family the COL2Al mutation involves the substitution of a basic 
arginine residue at amino acid position 704, by an uncharged polar cysteine residue. 
Arginine-cysteine conversions are not novel to the COL2Al triple helix which 
appears to have 'hotspots' for these changes [Table 3-III]. Possibly, the incorporation 
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of cysteine, which leads to crosslinking with other cysteine residues, results in 
abnormal procollagen molecules which are less stable and are therefore secreted less 
efficiently from the RER of the cell [Byers et al., 1991]. Furthermore, the abnormal 
molecules which are incorporated into the cartilage matrix interfere with the normal 
interaction between triple helices and other matrix components during fibril 
formation. In previous studies, biochemical investigations of the cartilage from 
persons with an Arg519Cys and Arg789Cys substitution have shown overmodified 
a 1 [II] chains which formed abnormal disulfide-bonded dimers and trimers [Eyre et 
al., 1991; Chan et al., 1993a]. Several unrelated persons with a mild form of SED 
have been shown to have cysteine substitutions at either Arg75 [Williams et al., 1993; 
Reginato et al., 1994; Bleasel et al.,1995] or Arg519 [Ala-Kokko et al., 1990b; 
Holderbaum et al., 1993; Pun et al., 1994; Williams et al., 1995). Other studies, [Chan 
et al., 1993b] described individuals with the more severe SEDC and who were 
heterozygous for an Arg789Cys mutation. The increased phenotypic severity in 
individuals with the Arg789 substitution is in keeping with the proposed gradient 
model which relates severity of skeletal abnormalities with the position of the 
mutation within the collagen triple helix [Horton et al., 1996]. There are, however, 
inconsistencies within this model and it is becoming evident that molecular findings 
cannot provide a definitive basis for the categorisation of all of the type II 
collagenopathies. Exemplifying this observation is the South African family in this 
study, which, by virtue of the position of the substituted amino acid, would be 
expected to have a severe skeletal dysplasia [Bachinger et al., 1993), but which in fact 
has very mild skeletal abnormalities. 
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The triple helix of the collagen molecule consists of a Gly-X-Y repeat in which X 
and Y can be any amino acid except cysteine and tryptophan [Byers et al., 1991]. 
In the South African family the relatively mild phenotype, which differed from 
more severe clinical manifestations observed in the other SEDC patients with 
Arg-Cys changes, can probably be ascribed to the position of the substituted 
amino acid within the Gly-X-Y repeat. In all of the other Arg-Cys conversions, 
the arginine residue occupies the Y position of the Gly-X-Y triplet repeat. The 
mild skeletal involvement observed in the South African family may be explained 
by the fact that the substituted nucleotide occupies the X position in the Gly-X-Y 
repeat. Although substitutions in the Y position may be tolerated, resulting in mild 
SED phenotypes [Byers et al., 1991], it is possible that substitutions in the X 
position may be even less deleterious; the X position probably is not as exposed to 
intra- and interhelical interactions as the Y position which sits on the outside of 
the triple helix [Chan et al., 1993]. Thus, although the substitution occurs close to 
the carboxyl terminus of the procollagen chain and would therefore be expected to 
cause a severe SEDC phenotype [Bachinger et al., 1993], in actual fact the 
affected persons in the South African family have relatively mild skeletal 
problems. In this context the findings of this study may contribute to an 
understanding of genotype-phenotype correlations. 
The COL2Al Arg-Cys mutation identified in this kindred underlies an unusual 
type II collagenopathy. This mutation could, however, also represent the first 
report of a non-termination COL2Al mutation in Stickler syndrome type 1, the 
first report of a mild SEDC, or the first report of a COL2Al defect in an MED 
phenotype. 
CHAPTER 4: 
SPONDYLOEPIPHYSEAL DYSPLASIA (SED): 
SED TYPE CAPE TOWN (SEDCT) AND 
NAMAQUALAND SED (NSED) 
4.1. INTRODUCTORY BACKGROUND 
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The spondylo-epiphyseal dysplasias (SED) are a clinically and genetically 
heterogeneous group of disorders characterised by abnormalities of growth and 
development of cartilage and/or bone. Classical SED can be subdivided into two 
forms: the autosomal dominant SED congenita (SEDC) and the X-linked recessive 
form, SED Tarda (SEDT). SEDC is characterised by clinical and radiological 
stigmata which are present at birth whereas SEDT has its onset in mid-childhood. In 
addition, the SED category encompasses a range of atypical phenotypes in which 
abnormalities of the spine and the ends of the long bones predominate [Horton, 1996; 
Rimoin, 1996]. 
The most likely candidate for the causation of SED is the COL2Al gene which 
encodes type II collagen, the major component of articular cartilage. COL2A 1 
mutations have been identified in a variety of cartilage disorders which constitute a 
clinical spectrum of skeletal dysplasias, many of them falling into the broad SED 
category. These disorders range from mild conditions such as Wagner syndrome and 
the Stickler syndrome type 1, through to the more severe Kniest dysplasia, 
spondyloepimetaphyseal dysplasia type Strudwick (SEMD), SED congenita (SEDC) 
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and the lethal achondrogenesis and hypochondrogenesis disorders (Table 4-1) 
[Kuivaniemi et al., 1997]. The most common mutations resulting in the SED 
phenotypes involve single base mutations which substitute the glycine residue in the 
Gly-X-Y repeat with a bulkier amino acid (Table 4-1). 
Early biochemical studies of cartilage from persons with vanous forms of 
chondrodysplasia provided evidence of changes in the collagen triple helix which 
relate to a gradient of phenotypic severity; generally, mutations occuring close to the 
carboxyl terminus result in the more severe chondrodystrophies whereas in milder 
phenotypes, mutations occurred closer to the amino terminus [Chan et al., 1991; 
Horton, 1996]. Some mutations do not, however, fit the gradient pattern. For instance, 
Gly895Ser, causes a SED phenotype although a severe chondrodysplasia would be 
expected because of its proximity to the carboxyl terminus [Winterpacht et al., 1995]. 
This chapter describes investigations on familial SED which has been encountered in 
two large kindred in the South African mixed ancestry population, viz. SED type 
Cape Town (SEDCT) and Namaqualand spondyloepiphyseal dysplasia (NSED) 
formerly known as ''Namaqualand hip dysplasia" [Beighton et al., 1984]. The two 
conditions are similar in that they are characterised by early-onset SED with OA, 
which progresses and leads to physical handicap by adulthood [Learmonth and 
Beighton, 1987; Sher et al., 1991]. Furthermore, both conditions are inherited as 
autosomal dominant traits and have been linked to the COL2Al gene [Sher et al., 
1991; Ramesar and Beighton, 1992]. In the present investigation, the role of COL2Al 
in the pathogenesis of the SEDCT and NSED phenotypes was examined. It was 
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shown that the two conditions share a common haplotype thus implying a founder 
effect. DNA sequencing studies revealed a common mutation within the COL2Al 
gene for both disorders. 
4.2. METHODS AND MATERIALS 
(i) The Family: 
SEDCT 
The SEDCT phenotype is characterised by stunted stature with predominant truncal 
shortening (Fig. 4-1 ). Moderately severe changes in the hip joint and vertebral bodies 
are evident and there are no extraskeletal manifestations. The propositus in the 
affected kindred had initially been diagnosed as having "dwarfism with premature 
degenerative OA of the hips" and his affected children were misdiagnosed as having 
"bilateral Perthes disease" [Beighton, personal communication]. The condition 
usually has its onset at puberty although a symptomatic six-year old child has been 
encountered. Progressive discomfort and disability can be alleviated by prosthetic hip 
replacement. Spinal malalignment was not observed in affected individuals but 
backache was common in adulthood. 
Radiographic changes are generally confined to the hip joint and spine, although 
involvement of the upper tibial epiphyses was present in two affected individuals. 
The original molecular investigation of type II collagen involvement in SEDCT was 
undertaken in the 3-generation family comprising 12 affected individuals. Southern 
blot analysis using COL2Al probes (HcolIIc [Sangiorgio et al., 1985] and Hco1IIFB 1 
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Table 4-1. Pathogenic glycine substitutions in type II collagen. 
SUBSTITUTION EXON CHONDRODYSTROPHY REFERENCE 
Gly 67 Asp 10 Wagner Korkko et al., 1993 
Gly 103 Asp 12 Kniest Wilkin et al., 1994 
Gly 154 Arg 15 SED Vikkula et al., 1993a 
Gly 247 Ser 19 mild SED Ritvaniemi et al., 1994 
Gly 274 Ser 21 mild SED Winterpacht et al., 1994a 
Gly 292 Val 21 SEMD Tiller et al., 1995 
Gly 304 Cys 21 SEMD Tiller et al., 1995 
Gly 574 Ser 33 hypochondrogenesis Horton et al., 1992 
Gly 604 Ala 35 hypochondrogenesis Freisinger et al., 1994 
Gly 691 Arg 38 achondrogenesis type II Mortier et al., 1995 
Gly 709 Cys 39 SEMD Tiller et al., 1995 
Gly 769 Ser 41 Achondrogenesis type II Chan et al., 1995 
Gly 805 Ser 41 hypochondrogenesis Bonaventure et al., 1995 
Gly 853 Glu 43 hypochondrogenesis Bogaert et al., 1992 
Gly 895 Ser 44 SED Winterpacht et al., 1995 
Gly 943 Ser 46 achondrogenesis type II Vissing et al., 1989 
Gly 997 Ser 48 SEDC Chan et al., 1991 
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[Strom et al., 1988]) demonstrated co-segregation of restriction length 
polymorphisms (RFLPs) with the disorder [Ramesar and Beighton., 1992]. A two 
point LOD score of 4.51 at 8=0.00 was obtained between SEDCT and the COL2Al 
markers (Table 4-II). 
NSED 
The NSED phenotype, so named because the affected persons have their antecedents 
in Namaqualand (a geographical region within the Northern Cape province of South 
Africa), is characterised by progressive degenerative OA predominantly in the hip 
joint and vertebral bodies. Affected individuals develop pain in the hips and in many 
instances, hip joint replacement surgery is necessary. NSED differs from SEDCT in 
that the condition has its onset in early childhood and the height of affected 
individuals is similar to their unaffected relatives (Fig. 4-2). Myopia which is present 
in some forms of SED, is not a consistent feature in NSED [Sher et al., 1990]. 
In NSED the femoral capital epiphyses are flattened and fragmented at an early age 
[Sher et al., 1990]. Prosthetic hip replacement is usually necessary as secondary OA 
develops in adulthood. Mild vertebral changes are present in about 60% of the 
affected individuals, with mild spinal malalignment and lumbar lordosis in a 
minority. 
A molecular investigation in a 5-generation NSED family, comprising 12 affected 
individuals, yielded a maximum two point LOD score of 7.98 at 9=0.00 between the 
disorder and the COL2Al markers [Sher et al., 1991] (Table 4-II). 
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Fig. 4 .1. The SEDCT kindred. Affected individuals are indicated with arrows. 
Fig. 4.2. The NSED kindred. Affected individuals are indicated with arrows. 
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Table 4-II. Two point LOD scores obtained for Southern blot/ RFLP analysis with 
COL2Al RFLP-probes. 
e 0.00 0.05 0.10 0.20 0.30 0.40 REFERENCES 
NSED 7.98 7.26 6.51 4.93 3.21 1.42 Sher et al., 1991 
SEDCT 4.51 4.16 3.78 2.96 2.04 0.97 Ramesar and 
Beighton, 1992 
(ii) Molecular Genetic Investigations 
The primary aim of the present study was to examine the COL2Al gene for mutations 
which were causing the SED phenotype in SEDCT and NSED. Thereafter, haplotypes 
were established using PCR-based microsatellite markers which were closely linked 
to the COL2Al gene in order to determine whether the molecular defects in each 
kindred were genealogically related to each other. 
Linkage Analysis 
Prior to 1990, blood specimens had been collected, with informed consent, by 
standard venipuncture techniques. DNA was extracted using the Genomix TM blood 
scale-up kit [Talent, Italy] (see Appendix 1, section 1.1.). Southern blot/RFLP studies 
had been performed [Sher et al., 1991; Ramesar and Beighton, 1992], and the 
remaining DNA stored for further analysis. The same DNA specimens were retrieved 
for investigation in the present study. The COL2Al chromosomal region, 12ql3.l l -
12q13.12 [Takahashi et al., 1990], was genotyped using primers for the COL2Al 3' 
VNTR [Stoker et al., 1985] and the microsatellite markers D12S361 and DI2S368 
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[Research Genetics, USA]. The localisation of these markers on chromosome 12 is 
given in Ch.2, section 2.2.1. Following standard PAGE, autoradiography and allele 
scoring. 
The PCR reactions were performed as described in Appendix 1 (section 2.1.2), with 
100-200ng of genomic DNA as templates; 5-1 Opmol of each primer; 1 µCi of a.-
[32P]dCTP; 200uM dATP, dCTP, dGTP and dTTP; and 0.5U of Taq polymerase, in a 
final volume of I Oµl. Samples were cycled 25 times in an Omnigene PCR machine 
using an annealing temperatures of 550c and the PCR products were resolved by 
PAGE and visualised by autoradiography (Appendix 1, section 2.1.3.). 
Linkage analyses were performed using the LINKAGE package Version 5.03 
[Lathrop and Lalouel, 1984] and the map order from the Genethon map of 
microsatellite markers for each chromosome. In all analyses the number of alleles for 
each marker was reduced to five, without loss of information in the family, in order to 
accommodate the computer program's limitations for numbers of alleles. Male and 
female recombination rates were taken to be equal. The condition was assumed to be 
autosomal dominant with full penetrance and a gene frequency of 0.001 was assumed 
for the disease locus. 
Mutation Analysis 
The exons correlating to the triple helical domain of COL2Al and their flanking 
sequences were amplified by a series of intronic primers (see Ch. 3, Table 3-II) using 
genomic DNA from affected persons as a template. Specimens from unaffected 
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relatives and spouses were used as controls. The PCR products were screened for 
mutations using SSCP analysis and confirmed by conformation sensitive gel 
electrophoresis (CSGE) by Dr Jarmo Korkko (as decribed in Appendix 1, section 
2.2.4) of the Allegheny University of the Health Sciences, Philadelphia, USA. 
Exons in which conformation polymorphisms were observed, were sequenced as 
described in Appendix 1 (section 2.2.2). The double-stranded PCR products were 
purified using the QIAquick protocol for eluting DNA from a gel matrix and 
sequenced, in both 5' and 3' directions, using the Sequenase version 2.0 DNA 
sequencing kit. Sequencing reactions were analysed on 6% PAGE gels which were 
dried at sooc and visualised by autoradiography. 
4.3 RESULTS 
The molecular study involved the confirmation of linkage of the SEDCT and NSED 
phenotypes to COL2Al using closely linked microsatellite markers for PCR studies. 
The pedigrees of the portions of the kindreds which were used for linkage analyses 
are shown in Fig. 4.3 and Fig. 4.4. No recombinations were observed using the 
intragenic VNTR and Dl2S368, Dl2S361 and Dl2S339. The LOD scores for 
SEDCT and NSED are listed in Tables 4-II and 4-III, respectively. Using these 
microsatellite markers the phase of the disorder and the associated haplotype was 
established. A common haplotype was found to be cosegregating with the two 
phenotypes (Fig. 4.3 and Fig. 4.4, respectively). Thereafter SSCP/CSGE analysis and 
DNA sequencing were performed in order to identify the determinant mutation in 
each disorder. 
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Using the intronic primers for SSCP, a conformational polymorphism was detected in 
exon 29 of the triple helical domain of COL2Al and was confirmed by CSGE 
analysis. The variant SSCP pattern cosegregated with both the SEDCT and NSED 
phenotypes (Fig. 4-3 and 4-4, respectively). Neither the unaffected family members 
nor their spouses exhibited the SSCP. This conformational change, upon sequencing, 
was found to be due to a G21011 T transversion (Fig. 4-5) which resulted in a 
Gly472Cys substitution in the type II collagen molecule. 
4.4 DISCUSSION 
In this study, a common haplotype and, subsequently, a common COL2Al mutation, 
has been identified in two families having two slightly different forms of SED. The 
two phenotypes, SEDCT and NSED, had previously been linked to COL2Al using 
RFLP analyses [Sher et al., 1991; Ramesar and Beighton, 1992]. In the present study, 
linkage analysis confirmed that the two autosomal dominant traits cosegregated with 
DNA polymorphic markers from the COL2Al locus. Furthermore, the haplotype 











316 611 416 617 6/7 314 611 416 417 417 6/7 314 3/4 6/7 
212 216 416 216 2/6 1/4 216 416 416 416 216 214 2/4 216 
' 1/S S/6 1/S 1/S 616 1/S 416 6/S 6/S 1/S 616 616 1/S 
D12S339 6/7 4/7 6/7 4/6 4/6 4/7 
DI2S36I 6/6 4/6 6/6 ? 4/2 4/6 
DI2S368 6/5 5/5 6/5 6/1 6/1 4/5 
Fig. 4.3. Haplotypes (A) and PCR-SSCP (B) analysis of exon 29 of the COL2A 1 gene in SEDCT. 
The SSCP change cosegregates with the disorder in the family. Haplotypes are indicated below 
each symbol. Shaded symbols represent the affected individuals and unshaded symbols the 
unaffected individuals. 
Table 4-III. Two point LOD scores obtained for microsatellite analysis with 
COL2Al polymorphic markers in the SEDCT family. The genetic distances 
between the markers and their proximity to the gene is given in Ch.2, Fig. 2-1. 
SEDCT 0.00 0.05 0.10 0.20 0.30 0.40 0.45 
D12S361 4.82 4.44 4.03 3.17 2.18 1.05 0.44 
D12S368 4.52 4.14 3.74 2.89 1.20 0.91 0.38 
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Fig. 4-4. Haplotypes and PCR-SSCP analysis ofexon 29 of the COL2Al gene in NSED family . 
Shaded symbols represent the affected individuals and unshaded symbols are the unaffected 
individuals. A.Haplotypes are indicated below each symbol. B.The SSCP change cosegregates 
with the disorder in the family. 
Table 4-IV. Two point LOO scores obtained for microsatellite analysis with 
COL2Al polymorphic markers in the NSED family. The genetic distances 
between the markers and their proximity to the gene is given in Ch.2, Fig. 2-1. 
SED 0.00 0.05 0.10 0.20 0.30 0.40 0.45 
D12S361 6.02 5.53 5.01 3.89 2.62 1.18 0.44 
D12S368 4.01 3.52 3.37 2.70 1.78 0.70 0.21 
VNTR 4.12 3.72 3.32 2.46 1.56 0.64 0.21 
(a). 
nt position 21011 
CCT GGC CCT CCT GGT CCC CCA normal sequence 
Pro Gly Pro Pro Gly Pro Pro 
aa position 472 
CCT GGC CCT CCT TGT CCC CCA variant sequence 








' ' ' ' 
G 
Gly472Cys Gff 21011 
T 
Pro 
' ' ' ' ' ' ' ' ' ' 
SEDCT NSED Normal 
ACGT ACGT ACGT 
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Fig. 4-5. Results of sequence analysis ofCOL2Al exon 29 in SEDCT and NSED (a) Partial 
sequence of exon 29. The normal and abnormal alleles are shown. (b) The sequencing gel 
showing the region of exon 29 in which the G21011 T transversion occurs. The arrow 
indicates the altered nucleotide. 
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In an extensive search for the mutation using CSGE analysis, a conformational change was 
observed in exon 29 of COL2Al. The cause of the condition in each family can probably be 
attributed to the Gly472Cys substitution which results from this mutation. Although the base 
change, which is common to SEDCT and NSED, has not been reported before, the 
substitution of a glycine residue by cysteine, which is not normally found in the triple helix of 
type II collagen, has previously been implicated in the aetiology of chondrodysplasias (Table 
4-V). Garofalo et al. [1991] showed that a Gly85Cys substitution in transgenic mice produced 
a lethal chondrodysplasia which was characterised by short limbs and trunk, craniofacial 
abnormalities and cleft palate. The histological features and the cartilage ultrastructure 
resembled that of the human SEDC phenotype. In humans, Gly304Cys and Gly709Cys [Tiller 
et al., 1995] substitutions have been found to cause SEMD which has some features of SEDC. 
In some instances of SEMD severely stunted stature, pectus carinatum and scoliosis are a 
feature [Murdoch and Walker, 1969]. In keeping with the phenotypic spectrum of severity in 
the collagen triple helix, Gly/Cys substitutions close to the carboxyl terminus reportedly cause 
the lethal condition, hypochondrogenesis, which is a form of short-limbed dwarfism [Mortier 
et al., 1995]. 
The phenotypes of SEDCT and NSED are both milder than the chondrodysplasias caused by 
the other Gly/Cys substitutions. Stunted stature was, however, an (albeit inconsistent) feature 
of the SEDCT phenotype. Furthermore, although there was no observed spinal malalignment, 
backache was common in the affected persons in this family. In the NSED family, the affected 
persons were not markedly shorter than their unaffected siblings. Mild spinal malalignment 
was observed in four people. There was no metaphyseal involvement in either of the kindred. 
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Table 4-V. Chondrodysplasia-causing gly/cys substitutions in type II collagen. 
MUTATION CHONDRODYSPLASIA REFERENCE 
Gly304Cys SEMO Tiller et al., 1995 
Gly472Cys SEOCT/NSEO Present study 
Gly709Cys SEMO Tiller et al., 1995 
Gly910Cvs Hypochondrogenesis Mortier et al., 1995 
Gly943Cys H ypochondrogenesis Mortier et al., 1995 
The reported SEO-causing COL2Al mutations have all been heterozygous mutations which map 
to the triple helical domain of the type II collagen molecule (Table 4-I), and are thought to act in 
a dominant-negative manner at the molecular level [Horton et al., 1995]. The most common 
SEO-causing mutations appear to be Gly/Ser substitutions. The Gly residues are considered to be 
critical for proper assembly of collagen chains into triple helices which occurs from the carboxy 
propeptide in the direction of the amino terminus. The substitution of Gly disturbs helix 
formation with adverse functional consequences. Collagen molecules which contain the mutant 
chains are thought to undergo premature degradation resulting in haploinsufficiency or they 
incorporate the mutant strands into collagen fibrils and affect the properties and function of these 
fibrils. In the South African family a Gly/Cys substitution results in a milder phenotype than 
reported for other Gly/Cys changes (Table 4-V). It has been proposed that the local amino acid 
context in which the amino acid substitution occurs may also contribute to variations in the 
phenotypic gradient of expression [Bi;ichinger et al., 1993]. It may therefore be prudent to 
suggest that in the South African family, the Pro residues which flank Gly472, protect the 
collagen monomer to some degree from the effect of the Cys substitution. Since, none of the 
other Gly residues which have been substituted by Cys (Table 4-V) have a similar amino acid 
environment, the resultant phenotypes are predictably severe. 
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The question arises whether SEDCT and NSED represent two separate, unrelated kindreds or 
whether they share a common progenitor in whom the mutation originated. The latter situation 
would be in keeping with the fact that both kindreds belong to the mixed ancestry population of 
South Africa, who have European, Khoi, Malay, and San admixture. The molecular findings, 
common haplotype and common genetic defect, suggest that SEDCT and NSED represent the 
same SED entity with mild variation in the final clinical manifestations. The phenomenon of 
variable phenotypic expression resulting from a single gene defect has previously been reported 
for the collagen genes and skeletal disorders. A mutation in exon 11 of COL2Al which causes an 
Arg75Cys substitution results in two different phenotypes, one with the typical stunted stature of 
SED [Williams et al., 1993] and the other with a tall stature [Bleasel et al., 1995]. Those authors 
suggested that the height difference reflects the complex multigenic factors which determine 
height. Furthermore, they proposed that the variable phenotypes caused by the single gene defect 
highlights the complex interrelationships between the underlying molecular events and the final 
clinical expression of the disorder. In another instance, Byers et al. [1991] proposed that the 
phenotypic variability which was observed in osteogenesis imperfecta as a result of mutations in 
the COL 1 A 1 gene, was due to many contributing factors including the type of mutation, the 
position of the mutation, the nucleotide environment as well as epigenetic factors. 
The best explanation for the identity of the genotype and the similar phenotype of SEDCT and 
NSED seems to be that they harbour the same founder mutation. The haplotype analyses, 
linkage, and ethnic background provide evidence of a genealogical link between the two families 
and the same ancestral mutation. It is likely that the variable clinical expressivity between the 
two skeletal disorders is due to the influence of additional genetic or environmental factors. 
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CHAPTERS: 
MULTIPLE EPIPHYSEAL DYSPLASIA (MED) 
5.1 INTRODUCTORY BACKGROUND 
Multiple epiphyseal dysplasia (MED) is an autosomal dominant disorder which is 
characterised by abnormalities of the epiphyseal growthplates of tubular bones. 
Minor involvement of the metaphyses and vertebrae is sometimes present 
[Beighton, 1988]. In affected persons, abnormal articular surfaces lead to 
degenerative joint disease particularly of the hip and knee joints [Hulvey and 
Keats, 1969]. 
There is a spectrum of severity within MED; the severe Fairbank type [Fairbank, 
1946] is characterised by short, stubby fingers and short limbs and usually 
presents in mid childhood. The milder Ribbing type presents as precocious OA of 
the hip with mild short stature and minimal involvement of the hands [Ribbing, 
1937]. There is, however, considerable overlap between the phenotypes with both 
inter- and intra-familial variation. Radiographic features of MED are age-related, 
and the changes in the epiphyses, digits and, in some instances, the spine, may be 
more evident with advancing age. 
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Although the classical forms of MED, SED and pseudoachondroplasia (PSACH) 
are clinically and radiographically distinct, there can be some overlap within the 
phenotypic spectrum [Beighton, 1988]. Ultrastructural changes in cartilage from 
individuals with PSACH and individuals affected with MED, Fairbank type, 
provided evidence that these two conditions belonged to the same family of bone 
dysplasias [Stanescu et al., 1993]. Langer et al. [1993] also suggested that the two 
conditions were closely related. Molecular findings have subsequently 
demonstrated that some forms of MED are allelic with PSACH (vide infra). 
Genetic heterogeneity in MED has been demonstrated by linkage to more than one 
genetic locus. The EDMl locus on 19p13.1 [Oehlmann et al., 1994; Knowlton et 
al., 1995] encodes the cartilage oligomeric matrix protein (COMP) [Newton et al., 
1994; Briggs et al., 1995]. The COMP gene has been identified, characterised and 
localized to the critical interval for EDMl [Newton et al., 1994; Briggs et al., 
1995]. COMP is a 524 kD pentameric glycoprotein of the cartilage extracellular 
matrix and is a member of the thrombospondin family of genes [Bornstein et al., 
1993]. The protein localizes specifically to the territorial membrane of cartilage 
chondrocytes. 
Mutations in the COMP gene result in either MED Fairbank or PSACH [Briggs et 
al., 1995; Hecht et al., 1995; Briggs et al., 1998]. In both disorders the mutations 
(Table 5-I) predominantly occur within the calmodulin-like repeat domain of the 
protein which encodes a calcium-binding motif. Aspartic acid residues which line 
this domain are positioned so that they can bind calcium ions. The localisation of 









































































































































































































































































































































































































































































































































































































































































an important role in calcium-binding within the cartilage extracellular matrix. 
More recently, Briggs et al. [1998] reported on mutations in the carboxy-terminal 
domain in PSACH and MED. Their findings imply an important structural or 
functional role for this domain in the cartilage extracellular matrix. 
The COMP mutations which have been identified in individuals with MED result 
in the substitution of a conserved aspartic acid residue at position 342 by a 
tyrosine residue in the third calmodulin-like repeat [Briggs et al., 1995] and a 
Cys371 Ser substitution in the fourth calmodulin-like repeat [Susie et al., 1997]. 
Both mutations result in the severe MED, Fairbank type, phenotype. Using SSCP 
and DNA sequencing, Hecht et al. [1995] identified eight COMP mutations in 
persons with PSACH. In six of these individuals the mutation was a deletion or 
substitution of a conserved aspartic acid residue which lined the calcium-binding 
domain. Another PSACH-causing mutation involved a 3 bp deletion which 
resulted in the elimination of a serine residue at position 459 in this domain. 
Briggs et al. [1995] identified a Cys328Arg substitution in the second calmodulin-
like repeat of COMP in a family with moderately severe PSACH and a deletion of 
a conserved aspartic acid residue between positions 372 and 374, in the fourth 
calmodulin-like repeat in another family with PSACH of similar severity. Susie et 
al. [ 1997] also reported a l 2bp deletion in the calcium binding domain which 
resulted in a mild PSACH phenotype. Briggs et al. [ 1998] reported on a further 12 
mutations in this domain, and two others which occurred in the carboxy-terminus: 
Thr585Met in a person with mild PSACH, and Thr585Arg in a person with MED. 
The EDM2 locus on lp32 which encodes COL9A2 [Perala et al., 1993; Warman 
et al., 1994] was shown to be linked [Briggs et al., 1994] in a kindred which had 
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characteristic MED features, but with only mild hip involvement. In this family a 
splice site mutation caused exon skipping and an in-frame deletion of 12 amino 
acid residues [Muragaki et al., 1996]. The resultant phenotype was mild, and the 
digits were not affected. Those authors suggested that mutations in COL9A2 
apparently have a stronger effect in the knees than do COMP mutations. This 
hypothesis is supported by the observation that the MED family which has been 
linked to COL9A2 has only knee pain with no clinical evidence of hip 
involvement, whereas the persons with MED linked to COMP, complained of hip 
and knee joint pains and, in some instances, discomfort was also experienced in 
other joints (Table 5-1). The symptoms of articular pain does not, however, 
necessarily correlate with the extent of involvement of the joint, and the value of 
using the anatomical location as an indicator of the underlying defect remains 
questionable. Additional genetic heterogeneity in MED has been demonstrated in 
two families; one with three affected siblings in a family of seven children in 
which neither of the parents was affected. The other family had classical features 
of AD-MED, type Fairbank. A number of candidate collagen genes which were 
tested for linkage to the condition in this family were excluded under models for 
dominance and recessiveness [Deere et al., 1995; Briggs and Cohn, unpublished 
data]. 
In the course of the current study, a South African family of western European 
stock with a mild form of MED was investigated. Linkage analysis with a number 
of candidate loci was undertaken in order to identify a candidate gene. The mutant 
gene, COMP, was localised and the pathogenic mutation was identified during the 
course of screening exons 10-14 (the region in which all of the 
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published mutations had been found) of that gene. The molecular findings which 
will form the subject of this chapter have been published during the course of this 
project [Ballo et al., 1997]. 
5.2. METHODS AND MATERIALS 
(i) The Family 
A South African family of western European stock was investigated. The affected 
family members, the proposita, her son, her brother and her deceased mother were 
shorter in height (154cm, 156cm, 157cm and 152cm) than their unaffected 
relatives who were of normal stature. Joint pains, mainly in the hips, but also in 
other large joints, were the predominant clinical problem. There was some 
limitation in the range of movement of the affected joints, but articular mobility 
was otherwise unremarkable. Three affected persons had received bilateral 
prosthetic hip replacements in adulthood. All the affected relatives had shortened 
digits. 
Radiographs of the proposita and her affected son showed significant flattening 
and irregularity of femoral heads, with some joint space narrowing and 
periarticular sclerosis. Other large joints were similarly affected, indicating 
secondary generalised OA (Fig. 5-1 ). The end plates of the vertebral bodies 
showed mild sclerosis and irregularity but there was no significant flattening. The 
skeletons were otherwise radiologically normal and in particular, there were no 
changes in the diaphyses or metaphyses of the tubular bones. (For this reason the 
diagnosis of PSACH, which is allelic to MED, could be discounted). 
Fig. 5-1. MED kindred: Antero-posterior radiograph of the pelvis of the proposita at the 
age of 45 years. The femoral head on the right side is irregular and somewhat flattened. 
Areas of patchy sclerosis and lucency are evident. Prosthetic joint replacement is evident 
on the left side. 
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In the hands, the phalanges were mildly short but not otherwise dysplastic (Fig. 5-
2a). Pattern profile analysis, using the method of Poznanski et al. [1972), showed 
that these changes were maximal in the metacarpals, with a trend to lesser severity 
in the distal phalanges (Fig. 5-2b ). 
(ii) Molecular Genetic Investigations 
Linkage Analysis 
Twenty ml of venous blood samples were collected under sterile conditions from 
each of 7 family members (2 affected and 5 unaffected) into tubes containing the 
anticoagulant, EDT A. The DNA was prepared by using the Genomix blood scale-
up kit [ Talent, Italy] (Appendix 1, section 1.1 ). In order to localise the disease 
gene, microsatellite markers which are in close physical proximity to the 
candidate genes, COL9Al and COL9A2 (see Ch. 2, section 2.2.3), and COMP 
(see Ch. 2, section 2.5.3.), were chosen. The microsatellite markers were typed by 
PCR, and the alleles resolved by PAGE (Appendix 1, section 2.1.3.). 
The PCR reactions were performed as described in Appendix 1 (section 2.1.2) 
with 100-200ng of genomic DNA as templates; 5-lOpmol of each primer; lµCi of 
cx-[32P]dCTP; 200uM dATP, dCTP, dGTP and dTIP; and 0.5U of Taq 
polymerase, in a final volume of 1 Oµl. Samples were cycled 25 times in a 
Ornnigene PCR machine and the PCR products were resolved by PAGE and 
visualised by autoradiography. 
Fig. 5-2(a). MED kindred: Antero-posterior radiographs of the hands of the proposita's son at the 
age of 21 years. The tubular bones are shortened but not dysplastic. 
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Fig. 5-2(b). MED kindred: Pattern profile analysis of the digits of the proposita age 45 
(F45) and her son, age 21 (M21 ). Both have shortness of all tubular bones with a minor 




Linkage analyses were performed using the LINKAGE package Version 5.03 [Lathrop and 
Lalouel, 1984] and the map order from the Genethon map of microsatellite markers for 
each chromosome. In all analyses the number of alleles for each marker was reduced to 
five, without loss of information in the family, in order to accommodate the computer 
program's limitations for numbers of alleles. Male and female recombination rates were 
taken to be equal. The condition was assumed to be autosomal dominant with full 
penetrance and a gene frequency of 0.001 was assumed for the disease locus. 
Mutation Analysis 
Candidate genes were further assessed for disease-causing potential by mutation screening 
through SSCP analysis. Following the observed lack of recombination between the MED 
phenotype and the COMP gene, exons 10-14 and flanking sequences were amplified using a 
series of intronic primers (Table 5-11) (exons 10-14 of the COMP gene were the first exons 
to be screened since this was the region within which most of the MED/PSACH mutations 
had reportedly been found). The PCR was performed in a total volume of 25µ1 using primer-
specific annealing temperatures (Table 5-11). The DNA strands were resolved on MDE gels 
and the SSCPs visualised by silver staining as described in Appendix 1 (section 2.2.1.2). 
Following the observation of SSCPs, the relevant exon was sequenced in order to 
determine the nucleotide changes which resulted in the bandshifts. The SSCP bands were 
excised from the PAGE gel. The single stranded DNA was eluted in sterile distilled 
water, purified using the QIAquick protocol and sequenced, using the Sequenase version 
2.0 DNA sequencing kit (see Appendix, section 2.2.2) as recommended by the 
manufacturer [USB, USA]. Sequencing reactions were analysed on 6% PAGE gels and 
visualised by autoradiography. 
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Table 5-II. Oligonucleotide primers for PCR amplification of exons 10-14 of the 
COMP gene (as described in Briggs et al., 1998). 
Exon PCRPrimer Product size Annealing 
(bp) Temperature 
(OC) 
10 5 '-TGAGGAGTGTGACCTTTGCC-3' 279 55 
5 '-AGCCGAA TCCCGCCTTCGGTG-3' 
11 5 '-CTTGGGCTCTGGTCCCGTGG-3' 181 57 
5 '-GCTT ACCCAGCTGGAGTCTG-3' 
12 5 '-ATTTCCTCTGTCTGATTATGG-3' 168 57 
5 '-CCAGAGACAA TGAGCTCTCCAG-3' 
13 5 '-GGGTAGCCTTTGACAAAACG-3' 223 55 
5 '-GTTAGGCACCAGGCGGCAG-3' 
14 
5 '-TGACTTT AGCCCACCGAGGG-3' 
281 57 
5 '-CTCAGCATAGGCCTCACTGTG-3' 
NOTE- For each exon the forward or sense primer is given on the top line and the 
reverse (antisense) primer is given below. DNA was amplified under the 
following PCR conditions: denaturation at 94°C for 30 secs, annealing 
temperature as tabulated above and extension at 72°C for 30 secs. 
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5.3. RES UL TS 
The structure of the family under investigation is shown in the pedigree in figure 
.5-3(a). Linkage analysis which is expressed as LOD scores, is presented in Table 
5-Ill. A LOD score of -5.52 at 8=0.00, led to the exclusion of COL9A2. No 
recombinations were observed between the condition and the markers associated 
with the COL9Al and COMP loci. The highest observed LOD scores were 0.78 
(D19S602 at EDMl) and 0.81 (509-8B2 and 509-12Bl at COL9Al) at 8=0.00. 
SSCP analysis of exons 10-14 of COMP revealed a bandshift in an amplified 
fragment containing exon 14. This polymorphism cosegregated with the condition 
in the family without exception (Fig. 5-3b) and was not seen in either the 
unaffected relatives or 50 random control samples representing unaffected 
individuals from the South Africans of western European origin. 
DNA sequencmg of exon 14 of COMP revealed a C to G transversion at 
nucleotide position 1594 (Fig. 5-4) in affected individuals and implied substitution 
of an uncharged polar asparagine residue by a charged lysine residue at position 
523 of the COMP protein. Because of this significant finding at the EDMl locus, 
COL9Al which showed no recombination with the MED phenotype was not 
investigated further. 
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Table 5-III. Two point linkage analyses between MED in the South African 
kindred and polymorphic microsatellite markers from the candidate gene loci. 
GENE [CA]n 0.00 0.05 0.1 0.2 0.3 0.4 
marker 
COL9Al 509-12Bl 0.75 0.66 0.56 0.37 0.19 0.05 
509-8 B2 0.81 0.71 0.61 0.40 0.21 0.06 
COL9A2 MYCLl -5.52 -0.52 -0.28 -0.09 -0.03 -0.005 




Fig. 5-3. MED kindred: Pedigree (a) and PCR-SSCP analysis (b) of exon 14 of the 
COMP gene in a South African MED kindred. Shaded symbols on the pedigree represent 
affected individuals. The SSCP change cosegregates with the disorder in the family. 
a. 
nt position 1594 
TGT CCG AAG AAC GCT GAA GTC normal sequence 
Cys Pro Glu Asn Ala Glu Val 
aa position 523 
TGT CCG AAG AAG GCT GAA GTC variant sequence 
Cys Pro Glu Lys Ala Glu Val 
b. 
A C G 
a\ 1 2 1 2 1 2 1 
C ' \ 
t \ 
~ ' \ \ a \ 









a , , 





Fig. 5-4. MED kindred: (a). Partial sequence of COMP exon 14. The normal and abnormal 
alleles are shown. (b). Results of sequence analysis of single stranded DNA. The 
sequencing gel showing the region of exon 14 of the COMP gene in which the base 




A mutation in the COMP gene has been identified in a South African family with a 
mild Ribbing type of MED. All of the COMP mutations which have been described 
elsewhere have resulted either in the severe, Fairbank, form of MED or PSACH. The 
clinical and radiographic features of these two phenotypes are distinct and diagnostic 
differentiation between the disorders is not difficult. It is becoming clear, however, 
that mutations in COMP unify phenotypes that span a phenotypic spectrum and, 
between the extremes, the phenotypic distinction may not be entirely clear cut; for 
instance, some patients with MED have mild changes in the metaphyses and 
vertebrae which could be regarded as a continuum with PSACH. 
COMP mutations are thought to act through a dominant negative mechanism. If both 
normal and mutant COMP monomers are combined into pentameric structures, then 
only one out of 32 possible pentamers will comprise five normal monomers. 
Although the fate of mutant monomers and the effect of varying the proportion of 
mutant monomers in the pentameric molecule is not known, it is obvious that a 
disturbance of calcium binding is involved in the pathogenesis of the resultant 
chondrodystrophies. COMP mutations which result in the MED phenotype result 
primarily in the substitution of conserved aspartic acid and asparagine residues 
within the calmodulin-like domain which are thought to line the calcium-binding 
pockets and to bind calcium by charge-charge interactions. These mutations are 
thought to decrease the calcium-binding ability of the pockets, without producing 
major effects on the structure of this region of the molecule [Briggs et al., 1998]. In 
contrast, the changes causing PSACH has a major effect on the overall structure of 
this COMP domain in that it affects the relative positioning of the calcium-binding 
pockets. 
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Briggs et al. [1995] demonstrated that mutations in COMP, in the region that encodes 
a putative Ca++ binding motif, were responsible for MED type Fairbanks and 
PSACH. In addition, Hecht et al. [1995] independently identified mutations in 
COMP which were causative of PSACH. In the South African kindred, the 
Asn523Lys substitution, while not in an evolutionarily conserved position, is located 
immediately adjacent to a positionally conserved aspartic acid residue within the 
eighth calmodulin-like repeat of the molecule. If the asparagine at position 523 is 
also involved in the co-ordination of calcium ions, then a change in the local ionic 
envirorunent, by the substitution of a larger, charged lysine residue, might reduce the 
charge-charge interactions which usually occur between Ca++ ions and the receptive 
amino acids in this region. As a consequence, the structural integrity of the COMP 
monomer may be compromised and/or an effect on calcium-dependent binding 
between COMP and other components of the extracellular matrix may result. 
Due to the informativeness of the markers and the small family size, it is not 
surprising that an inheritance pattern which suggests an association to more than one 
locus, was observed. This finding highlights the potential uncertainty in using just 
linkage analysis in diagnostic studies for small families with a genetically 
heterogeneous disorder and argues that the identification of a mutation is necessary 
to confirm the association between the gene and the condition. 
The identification of a mutation in the COMP gene in this family expands the range 
of phenotypes that can be produced by COMP mutations, defining a spectrum of 
allelic disorders from severe PSACH through mild MED. 
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CHAPTER 6: 
FAMILIAL PRIMARY GENERALISED OSTEOARTHROPATHY 
6.1. INTRODUCTORY BACKGROUND 
Primary generalised OA is a common, slowly progressive disorder affecting mainly the 
weight-bearing joints and is a major cause of pain and disability in the elderly [Mankin et 
al., 1974]. Although the condition is mostly sporadic, familial clustering may be explained 
by shared genetic and environmental influences or a combination of the two [Wordsworth, 
1995]. Twin studies have provided evidence for a strong genetic influence which was 
estimated to be between 39 and 65%, in certain forms of OA [Spector et al., 1996]. 
The heritability of primary generalised OA without underlying skeletal involvement, 
termed familial primary generalised OA (FOA) [Meulenbelt et al., 1997], has been 
extensively debated. Evidence of defective collagen genes in some persons with OA [Ala-
Kokko et al., 1990; Knowlton et al., 1990; Prockop et al., 1997] was contrary to the 
general belief by rheumatologists that generalised OA was not a heritable condition. 
Evidence for a genetic predisposition in OA was provided by the observations of 
Kellgren et al. [1963] and Doherty et al. [1983]. These investigators found that OA 
associated with enlargement of the terminal joints of the fingers (Heberden's nodes) 
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was sex-influenced, being dominant with full penetrance in females, but recessive in 
males. Kellgren and Moore [1952] found clinical evidence of a direct association between 
Heberden's nodes and OA of other joints including the spine and the knees. Their findings 
were confirmed by a radiological study on a random sample of a Lancashire population 
[Kellgren and Lawrence, 1958]. 
Support for COL2Al involvement, and thus a genetic basis to FOA, was provided by 
Vikkula et al. [1989] and Palotie et al. [1989] who demonstrated that DNA markers 
from the COL2Al locus cosegregated with the condition in two kindred. However, 
despite extensive mutation screening of COL2Al, they were unable to identify a 
pathogenic mutation. Many molecular investigations have been concerned with 
determining the involvement of the COL2Al gene in which mutations have been 
identified in some families with early onset OA associated with a mild 
chondrodysplasia [Pun et al., 1994; Bleasel et al., 1995]. Other investigations seeking a 
genetic predisposition for Heberden's nodes in a patient cohort in the UK [Priestley et 
al., 1990] and in a Finnish isolate [Vikkula et al., 1993a], however, revealed no definite 
association between this condition and a number of DNA polymorphisms in the 
COL2Al gene. 
In a recent investigation [Meulenbelt et al., 1997], linkage analysis for FOA in a large 
Dutch family of Jewish descent was extended to other candidate genes which are 
important for the integrity of articular cartilage. The findings resulted in the exclusion 
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of the collagen genes COL2Al, COL9Al, COL9A2, COLl lAl, COL11A2, and the 
non-collagenous genes COMP, CRTLl, CRTM, CCAL2 and matrix metalloproteinase 
3 (MMP3), in that kindred. Other genes which were tested but not excluded were 
COL9A3, DCN, LOX (the lysyl oxidase gene which is defective in Cutis Laxa and 
PLOD (the gene for procollagen-lysine, 2-oxoglutarate 5-dioxygenase which is 
defective in type VI Ehlers-Danlos syndrome). 
The present study involves a candidate gene-based analysis of a large South African 
family of Jewish descent with FOA. The affected members of this kindred, manifesting 
with knee pain and Heberden's nodes, were investigated by clinicians in the Department 
of Human Genetics at UCT. Although a limited number of family members were 
available for study, they were deemed sufficient to provide an indication of a possible 
aetiology for FOA in the kindred. 
6.2. METHODS AND MATERIALS 
(i) The Family 
A pedigree of the 59 membered, 4-generation kindred is shown in Fig. 6-1. The family 
comprises 18 clinically confirmed affected individuals, and three who were anecdotally 
thought to be affected. The youngest affected individual (IV-6) was 25 years of age at 
the time of clinical evaluation. Individuals were classified as 'affected' on the basis of a 
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long-standing history of knee and ankle pam, Heberden's nodes, and radiological 
evidence. Detailed clinical data and radiolographs were obtained from three of the 
affected members (ill-18, III-26 and IV-6). Informed consent was provided by all 
participants prior to inclusion in the study. Blood specimens were collected from these 
persons together with three other affected relatives (II-18, III-7 and III-10) and five 
completely asymptomatic adult relatives (III-2, III-17, III-28, IV-4, IV-5 and IV-7) who 
were accorded an 'unaffected' status. The designated affection status of the deceased 
individuals in the family was surmised information from their close living relatives and 
from the transmission of the phenotype to their living offspring. 
The affected individuals in this kindred presented with pain in the knees and ankles in 
their early twenties. Involvement of the terminal joints of the fingers subsequently 
developed and Heberden's nodes were present in the two older individuals (III-18 and 
III-26) at the time of clinical assessment. There was no clinical or radiological evidence 
of an associated chondrodysplasia in the affected persons who were investigated 
[Beighton, personal communication]. Furthermore, there was no evidence of stunted 
stature or brachydactyly which would categorise the condition as MED, and no 
evidence of eye or hearing abnormalities which would group them with the Stickler 
syndrome. Only findings which were typical of a generalised OA were observed. The 
OA in the family was progressive and lead to severe physical handicap in the older 
individuals. Radiographs of the knees, ankles and spine showed narrowing of joint 
spaces and large bony spurs (osteophytes), which were indicative of OA (Fig. 6-2,a-d). 
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Fig. 6-1. Pedigree of a South African kindred manifesting with primary generalised OA and 
Heberden's nodes, inherited as an AD trait. 
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of the hands showed a narrowing of the joint spaces and osteophytes in the distal finger 
joints (Fig. 6-2e). 
(ii) Molecular Investigations 
Individual III-18 presented herself and her affected son, aged 25 years (IV-6) at the 
Department of Human Genetics, UCT, for a genetic evaluation. Prior to molecular 
investigation, other accessible family members who were recruited for this study 
included individuals II-18, III-2, III-7, III-10 and III-28. In order to undertake an 
extended linkage analysis peripheral blood samples were collected, with informed 
consent, by venipuncture from all available affected and unaffected family members. A 
limited number of relatives were available for study since most of them had emigrated 
and currently reside in distant countries. A total of twelve family members were 
accessible and finally used for linkage analysis. 
The primary candidate for this study was COL2Al to which FOA has previously been 
linked [Vikkula et al, 1989]. Eighteen additional candidate genes were screened using 
closely linked microsatellite markers, the majority of which were selected from the 
published genetic maps [Gyapay et al., 1994, Dib et al., 1996]. The markers (Ch. 2, 
Table 2-II) had an average separation of 1-lOcM as determined by use of the Genome 
database (http://www.gdb.org) and the Genethon linkage map [Dib et al., 1996]. The 
candidate genes which were screened were COL6A2, COL6A3, COL9Al, COL9A2, 
COL9A3, COLlOAl, COLl lAl, COL11A2, AGCl, DCN, FMOD, LUM, MMP3, 
COMP, CCAL2 and CRTLl. In addition, the non-articular collagen marker, CRTM, 
was also screened. 
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Fig. 6-2(a). FOA: Antero-posterior radiographs of the knee joints of an affected female, aged 
56 years (III-18). Marked narrowing of the joint space and periarticular sclerosis are evident 
in the right knee. Prosthetic joint replacement has been undertaken in the left knee. 
Fig. 6-2(b ). FOA: Antero-posterior radiograph of the pelvis of an affected male aged 66 
years (111-26). The hip joints are irregular and sclerotic. 
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Fig. 6-2(c). FOA: Radiographs of the ankle of an affected female aged 56 years (III-18).The 
joint space is narrow and irregular with large osteophytes and considerable sclerosis. 
Fig. 6-2(d). FOA: A lateral radiograph of the spine of an affected male aged 66 years (III-
26).The intervertebral spaces are narrowed and uneven; endplate sclerosis and anterior 
osteophytes are evident. 
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Fig. 6-2(e). FOA: A radiograph of the hand of an affected male aged 66 years (III-26). The 
middle and distal interphalangeal joints are narrow and irregular with significant 
osteophytes. The carpo-metacarpal and metacarpal-phalangeal joints in the thumb are 
similarly affected. 
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Following the preliminary study, additional molecular investigations required a further 
eight polymorphic microsatellite markers which span the COLl lAl region and which 
were selected off the Genethon human linkage map [Gyapay et al., 1994, Dib et al., 
1996]. These markers included D1S497, D1S420, D1S486, D1S429, D1S485, D1S495, 
and D1S457 (Table 6-II). A final investigation which was undertaken in collaboration 
with Dr Leena Ala-Kokko (Finland), involved screening the family with two 
polymorphic intragenic markers for COLl lAl described by her group (personal 
communication) viz. a tetranucleotide repeat in intron 16: F-5' ggccctcgaggcgtccag-3 '/ 
R-5 ' cagcatgattaagcgaagtgac-3' and a trinucleotide repeat in intron 17: F-5 ' 
cctgtggcagttcactctgg-3 'I R-5' acctttgtcacctggcagac-3'. 
Genomic DNA was extracted from whole blood using standard techniques (Appendix, 
section 1.1.) and the DNA was genotyped using PCR of microsatellite markers 
(Appendix 1, section 2.1.2.). Alleles were separated according to size on PAGE gels, 
dried at 80°C, and exposed at -70°C for autoradiography (Appendix 1, section 2.1.3.). 
Linkage analyses were performed using the LINKAGE package Version 5.03 [Lathrop 
and Lalouel, 1984] and the map order from the Genethon map of microsatellite markers 
for 1 p21. In all analyses the number of alleles for each marker was reduced to five, 
without loss of information in the family, in order to accommodate the computer 
program's limitations for numbers of alleles. Male and female recombination rates were 
taken to be equal. The condition was assumed to be autosomal dominant and in the 
absence of data on penetrance and expressivity, a value of 0.9 for penetrance was used 
106 
in order to allow for a minor fraction of non-penetrance that may be encountered in this 
disorder. A gene frequency of 0.1 was assumed for the disease locus. 
6.3. RES UL TS 
Twelve members of this family were genotyped with thirty polymorphic markers (nine 
of them being intragenic) from eighteen candidate gene loci. Two-point LOD scores 
and recombination fractions are shown in Table 6-1. On the basis of Z < -2.00 at 8=0.05 
[Lester et al. , 1990], COL2Al, COL6A3, COL9Al, AGCl and MMP3 could be 
excluded from causing the FOA phenotype in the South African kindred. Meiotic 
recombinations with intragenic markers for COL6A2, COLlOAl, COL11A2, CRTLl , 
DCN and CRTM suggest that these .genes could also be excluded as FOA candidates 
(although intragenic recombinations have been known to occur within a mutant gene). 
The remaining genes which were investigated viz. COL9A2, COL9A3, COMP, LUM, 
FMOD and CCAL2 genes could not be excluded by two-point linkage analysis. 
No recombinations were observed between the FOA phenotype and markers, D1S223 
and D1S206, located about 5cM away from the COLllAl gene on lp21. Two point 
LOD scores revealed a positive LOD score of 1.31 at theta=0.00 (D1S223) and 1.94 at 
theta=0.00 (D1S206), suggesting that COLl lAl could not be excluded as the locus for 
FOA in this family. Further investigation of COLl lAl was undertaken using additional 
markers flanking the locus. Disease-associated alleles were determined for 111-18 and 
her son IV-6 and the haplotype which appeared to be segregating with the condition 
was constructed (Fig. 6-3). The parental haplotypes of five individuals, 11-18, 111-2, III-
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7, III-10 and III-26, could not be determined because their parents were deceased. For 
this reason, the phase of the OA phenotype in these additional individuals was 
determined by looking for the same haplotype which appeared to be segregating with 
the condition in III-18 and N-6. Similar haplotypes for the region between D 1 S420 and 
D1S495 were identified in the affected individuals II-18, III-7 and III-10 but not in the 
unaffected person, III-2 (Fig. 6-3). 
Meiotic recombinations were observed between the OA phenotype and the markers 
within and flanking the COLl lAl gene, thereby excluding it as a candidate for FOA in 
this kindred (Fig. 6-3, Table 6-II). Moreover, two recombination events in the affected 
individual, III-26, allowed the delineation of a candidate region to a 3-cM interval 
spanning D1S223 and D1S206 which is approximately 5cM away from the COLllAl 
locus. 
Table 6-1. Two point LOD scores between FOA in the South African kindred and 
polymorphic microsatellite markers from the candidate gene loci . 
[CA]n 
GENE marker 0.00 0.05 0.1 0.2 0.3 0.4 
D12S361 - 00 -2.66 -1 .58 -0.64 -0.23 -0.05 
COL2Al VNTR -00 -2.24 -1.42 -0.69 -0.34 -0.14 
[CA]n - 00 -0.50 -0.05 0.21 0.18 0.06 
COL6A2 D21S1446 - 00 -0.95 -0.49 -0.16 -0.05 -0.01 
D2S338 - 00 -1.17 -0.67 -0.27 -0.10 -0.02 
COL6A3 D2S345 - 00 -2.25 -1.38 -0.59 -0.23 -0.05 
509- 8B2 - 00 -2.31 -1.28 -0.44 -0.12 -0.01 
COL9Al 509-12Bl -00 -2.36 -1.30 -0.48 -0.15 -0.03 
MYCL-1 - 00 0.94 0.99 0.78 0.47 0.18 
COL9A2 D1Sl598 -oc 0.85 0.94 0.81 0.55 0.27 
COL9A3 D20S64 - 00 -1.76 -1 .00 -0.37 0.11 -0.01 
COLlOAl RFLP -00 -0.79 -0.34 -0.06 0.00 -0.01 
D1S223 1.31 1.16 1.02 0.74 0.47 0.22 
COL11Al D1S206 1.94 1.73 1.51 1.06 0.62 0.23 
D6S291 - 00 -0.14 0.27 0.23 0.11 0.02 
COL11A2 D6S273 - 00 -1.81 -1.05 -0.45 -0.20 -0.08 
RFLP-Mspl - 00 -1.10 -0.62 -0 .25 -0.12 -0.05 
AGCI VNTR - 00 -2.20 -1.16 -0.31 0.01 0.08 
CRTLI VNTR - 00 -0.84 -0.37 -0.06 -0.01 0.01 
D19S215 - 00 -1 .24 -0.74 -0.32 -0.12 -0.02 
COMP D19S2l2 - 00 -0.46 -0.23 -0.06 -0.01 -0.00 
D12S101 - 00 -0.35 0.05 0.22 0.14 0.01 
LUM D12S1064 - 00 0.05 0.14 0.04 -0.11 -0.15 
DCN [CA]n - 00 -1.22 -0.75 -0.43 -0.33 -0.22 
Dl S 1660 - 00 -1.86 -1 .09 -0 .44 -0.16 -0.04 
FMOD D1S306 - 00 -0.92 -0.46 -0.14 -0.04 -0.01 
CRTM VNTR - 00 -0.39 -0.19 -0.05 -0.01 0.00 
MMP3 DI 1S898 - 00 -2.59 -1.53 -0.63 -0.23 -0.05 
D8S539 · -00 -0.03 0.13 0.14 0.07 0.02 
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Fig. 6-3. An abridged pedigree of the South African kindred. The genotypes for markers 
from the COLI lAl locus are indicated below each individual. Haplotypes are depicted as 
shaded bars, the disease haplotype being shaded in black. The haplotypes for III-2 are 








Table 6-II. Microsatellite markers selected from the Genethon map which were used 
to screen the South African kindred with FOA at the COLl lAl locus. The genetic 
distances between the markers, in the order of appearance on the map, are indicated. 
According to the Stanford Human Genetic Center 
[http://www.shgc.stanford.edu/mapping/rh/mapsv2/search I.html], the COL 1 lA 1 
gene (indicated by intronic markers 16 and 17) lies between the markers D 1 S495 and 
D1S248. 
GENETHON GENETIC 
[CA]n DISTANCE 0.00 0.05 0.10 0.20 0.30 0.40 
MARKER (cM) 
D1S497 -00 -1.38 -0.80 -0.30 -0.09 0.02 
0 
D1S420 -00 -0.59 -0.14 ; 0.14 0.13 0.04 
3 
,,'\i •. 
D1S223 If 1.31~ 1.16 1.02 0.74 0.47 0.22 
0 ~ . lb 





D1S429 -00 0.57 0.71 0.68 0.51 0.27 
0 " -' '" .t; 
·• 
~; .,""'-




/ ;'f I 
Marker 
16 -00 -0.71 -0.28 -0.02 -0.01 -0.03 
Marker 
17 - -00 -2.79 -1.71 -0.78 -0.35 -0.12 ,-~ 
1 
D1S248 -00 -0.44 -0.22 -0.08 -0.03 -0.01 
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6.4. DISCUSSION 
In a candidate gene screen for linkage of inherited primary generalised OA (FOA) 
without an underlying skeletal dysplasia, the genes encoding eighteen cartilage 
components were screened. Twelve family members were studied, six of whom were 
affected with the condition. 
A significant LOD score of <-2.00 at 8=0.05 in this study has demonstrated that the 
COL2Al gene, which has previously been associated with FOA [Vikkula et al. , 
1989], is not involved in the aetiology of FOA in this South African kindred. On the 
same basis, the present findings indicate that the COL6A2, COL9Al, COLlOAl, 
COLl lAl, COL11A2, AGCl, CRTLl, DCN and the CRTM genes are also not 
primarily involved in this condition. The other candidate genes which were 
investigated could not, however, be excluded from involvement; total exclusion 
would require that either intragenic markers be used or that each gene be screened for 
a pathogenic mutation if the family is not sufficiently informative for linkage. 
The present findings do, however, suggest that a candidate gene for FOA may be 
localised to lp21, to a genomic region between D1S223 and D1S206. These markers 
are thought to lie at least 5cM telomeric to the COLl lAl gene and have previously 
been used to demonstrate linkage between COLllAl and a chondrodysplasia 
phenotype [Richards et al., 1996]. The COLllAl gene has recently been shown to 
harbour a mutation which results in the chondrodysplasia, Stickler syndrome type 2 
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[Snead et al., 1994; Richards et al., 1996]. In the South African kindred, however, 
meiotic recombinations using highly informative intragenic markers for COLllAl 
indicated that this gene did not harbour the pathogenic mutation. It is possible, 
therefore, that a gene for FOA, as yet unidentified, may be localised to the 1 p21 
region, approximately 5cM telomeric to the COLl lAl gene. The South African 
family under investigation, however, comprised only a small number of people who 
were accessible for study, and it is therefore possible that the apparent lack of 
recombination in the lp21 region may be spurious. As mentioned in Ch. 4 (section 
4.4) this phenomenon is not uncommon when performing linkage analysis in small 
families and can falsely imply an association between a marker and the disorder in 
such an investigation. It is therefore possible that molecular investigations of further 
candidate genes may also yield non-recombinations in this small kindred; mutation 
analysis of each gene, where possible, will therefore be necessary to verify the 
linkage results. 
The findings in this South African kindred support those of Meulenbelt et al.[1997] 
who demonstrated genetic heterogeneity for FOA. In order to achieve definitive 
results, it would, however, be necessary to increase the number of family members 
for this investigation. The limitations in dealing with a condition such as this, which 
is relatively mild until mid-adulthood, is that the parents of the affected individuals 
may be deceased by the time of clinical evaluation, thus placing a constraint on 
linkage analysis. It may therefore be necessary to inform these kindred of the need to 
undertake molecular investigations presymptomatically, thereby providing risk 
estimates for family members, and thus enable affected individuals to plan ahead. The 
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recognition of a specific molecular basis for the disorder will facilitate 
presymptomatic diagnosis. In this way, although the condition is not life-threatening, 
the knowledge of having a predisposition to pain and discomfort which would impose 
limitations on everyday activities and which may necessitate surgical procedures at 
some stage, could enable individuals to plan ahead for suitable employment and 
lifestyle. 
Apart from this potential benefit, the FOA phenotype probably is a closer 
approximation to the generalised 'sporadic' OA, which is a major health and 
socioeconomic burden in any country, than the secondary forms of OA. Identification 
of the determinant gene(s) for FOA may realistically contribute towards the 
understanding of the genetic and biological mechanisms which play a role in age-
related generalised OA. The work presented here may be considered preliminary but 
should provide impetus for the further recruitment of as many members of the kindred 
as possible, and probably to participate in an international collaborative mapping 
exercise for FOAs. 
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CHAPTER 7: 
MSELENI JOINT DISEASE (MJD) 
7.1. INTRODUCTORY BACKGROUND 
Mseleni joint disease (MID) is an unusual form of precocious and generalised OA 
which was identified in several hundred persons within a small area in the remote, 
rural Mseleni region in Northern Kwa-Zulu Natal, South Africa. The condition 
has its onset in mid-childhood and is characterised by progressive degenerative 
changes in the hip joint and, to a lesser extent, the spine and other weight-bearing 
joints [Lockitch and Fellingham, 1973; Solomon et al. , 1976]. These changes lead 
to secondary OA and serious disability usually from the third decade of life [ du 
Toit, 1979]. In addition to the pain and handicap experienced by affected persons, 
MID places a heavy burden on the state, including the costs of hospitalization for 
prosthetic joint replacement and disability pensions. 
Since individuals with MID may have vertebral anomalies [Lockitch, 1974], the 
condition may be regarded as a form of spondylo-epiphyseal dysplasia (SED). 
Another peculiar feature of MID is the gross dwarfism which occurs in about 
0.1 % of the Mseleni population as a whole [Viljoen et al., 1993]. Apart from 
brachydactyly 
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and shortened long bones, these individuals share the clinical and radiographic 
phenotype of conventional MID. 
MID initially came to general medical attention in the early 1970's. The findings 
of a genealogical and radiological study of 5 large kindred, was suggestive (but 
not conclusive) of an autosomal dominant pattern of inheritance [Lockitch, 1974]. 
The observation that the condition was localised within a small area, and the lack 
of an apparent Mendelian inheritance pattern within affected kindreds, suggested 
that environmental factors might be responsible for the phenotype. Early 
investigations on the affected MID population, however, failed to reveal 
significant abnormalities in biochemical factors between affected and control 
populations [Burger et al., 1973]. No disturbances of blood group frequencies 
were detected. Biochemical studies of the serum and food and water supplies 
failed to reveal any differences between affected and control groups [Lubbe et al., 
1973]. In contrast, evidence of the hip dysplasia among affected relatives 
supported the concept of a genetic basis for this disorder. 
Interestingly, the MID phenotype resembles that of a severe, progressive form of 
SEO found in two small isolates of jungle-dwellers in Kamataka, southern India 
[Agarwal et al., 1994]. This latter condition, termed Handigodou joint disease 
(HID), has a similar clinical and radiological phenotype as MID. The presence of 
unaffected communities from culturally different caste groups living in the same 
area, is evidence against an acquired aetiology. Pedigree data in HID are 
suggestive of autosomal dominant inheritance [Agarwal et al., 1997]. 
116 
Because of a lack of Mendelian inheritance, MID should be considered a complex 
trait [Lander and Schork, 1994]. Complex traits are often polygenic and, due to 
features such as incomplete penetrance, phenocopy and genetic heterogeneity, these 
traits may not be amenable to simple segregation analysis. Lander and Schork [1994] 
described four methods of genetically dissecting complex traits which comprise 
linkage analysis, allele-sharing methods, association studies and experimental crosses 
in animal models. 
Linkage analysis is based on family studies and attempts to explain the inheritance of 
phenotypes and genotypes in a pedigree. Allele-sharing methods involve the study of 
affected relatives in a pedigree to determine how often a chromosomal region is 
inherited from a common ancestor. The simplest form of allele sharing is sib pair 
analysis which has played a major role in the localisation of the gene for type I 
diabetes and the angiotensinogen gene for hypertension [Jeunemaitre et al., 1992], 
amongst others. Association studies are "case-controlled", based on comparing allele 
frequencies in unrelated affected individuals with unaffected individuals from the 
same population. These studies do not concern inheritance patterns. A positive 
association between a gene and marker can be established if an allele occurs at a 
significantly higher frequency among the group of affected people but not in the 
control group. Furthermore, in a genetically isolated population, linkage 
disequilibrium could prove to be a powerful mapping tool and could also identify a 
common ancestor for disease-causing alleles. Of the four methods mentioned above, 
association studies are the most suited to the present genetic dissection of Mseleni 
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joint disease and in particular to testing the hypothesis that MID is due to a founder-
effect. Earlier investigations using segregation analysis [Lockitch, 1974] did not shed 
any light on a suspected founder-effect theory for MID. 
It is of crucial importance to association studies that a suitable "control" group of 
individuals is selected. Family-based association studies and the development of 
"internal controls" or AFBACS (affected family-based controls) provides a powerful 
strategy for identifying suitable controls [Thomson, 1995]. The AFBACS are the 
parental alleles which are never transmitted to an affected child or to an affected sib 
pair. This method of ascertainment provides an unbiased estimate of the control 
alleles for markers which are closely linked to a gene. False associations which result 
from ethnic admixture, migration and population stratification can therefore be 
avoided. The use of AFBACS and sib pair analysis led to the association of IDDM 
and an allele of the insulin gene [Thomson, 1989] where haplotype-sharing data had 
showed no evidence of linkage [Spielman et al., 1989]. In a random-mating 
population with no stratification, no admixture and no migration, for 9=0.00, the 
family-based study is equivalent to a case-controlled study. 
The Department of Human Genetics, UCT, first became involved with the Mseleni 
population over two decades ago. The epidemiological findings at that time were 
inconclusive [Lockitch, 1974]. More recently, over a period of three years (1993-
1995), staff members visited the Mseleni district in order to reassess the genetics and 
to obtain biological material for a pilot molecular genetic investigation of MID. 
Blood specimens were obtained mostly from unrelated individuals because complete 
118 
families were not always accessible. In many instances the parents of affected 
individuals were deceased, limiting the availability of nuclear families and sibpairs. 
The present investigation was designed with the objective of finding an indicator of a 
possible aetiology for the MID phenotype. It was envisaged that the findings would 
facilitate the implementation of a large scale study of the Mseleni population and the 
individuals affected with MID. In order to determine whether MID had a genetic 
component, in the present study, four different avenues of research were undertaken. 
Firstly, an association between MID and the Human Leukocyte Antigen (HLA) 
complex was examined since other complex disorders such as rheumatoid arthritis 
[Mody et al. , 1989] and diabetes [Copeman et al., 1995] have associations with a 
specific haplotype of HLA. Secondly, articular cartilage specimens were examined 
histologically for structural abnormalities which could be indicative of the underlying 
biochemical and genetic defect. Thirdly, allele frequencies in the affected population 
were compared with those of unaffected individuals from the same geographical area. 
Some of these findings which are incorporated into this chapter have been published 
during the course of this project [Ballo et al., 1996]. Lastly, as COL2Al is known to 
be defective in numerous chondrodysplasias which have OA as a component, 
mutation analysis of the gene was undertaken in an affected person with the typical 
SED phenotype and in a dwarfed individual from the Mseleni community, in order to 
identify possible disease-predisposing changes. 
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7.2. METHODS AND MATERIALS 
(i) The Mseleni district 
This area has been described elsewhere [Lockitch, 1974] and is briefly summarised 
here. The Mseleni region, falls in the coastal belt of subtropical forest or dense 
evergreen bush. The Mseleni area is about 13x 18km and is situated in the Ubombo 
district of northern Kwa-Zulu Natal. It lies midway between St. Lucia (south) and 
Kosi Bay (north), on the western shore of Lake Sibaya, which is about 50km south of 
the Mozambique/ South Africa border. 
(ii) The Mseleni Population 
Affected group 
The samples for the pilot study initially comprised 30 unrelated, unaffected MID 
persons (13 males and 17 females) with an age range of 40-90 years. At a later stage, 
a further 17 affected individuals became available for study. Affected individuals 
were identified by virtue of having widespread involvement of the epiphyses and 
vertebral bodies, and, where possible, the diagnosis was confirmed radiologically. 
In many instances the pattern of inheritance could not be determined because of 
complicated pedigree structures. In some instances, families had either both parents 
affected, all of the offspring affected or marriages had occurred between affected 




The Mseleni population is geographically isolated. The socioeconomic status of the 
population, and lack of migrational incentives has resulted in the population being 
relatively homogeneous. This homogeneity is advantageous for identifying a control 
group of individuals that is well-matched to affected individuals for association 
studies. Furthermore, it is likely that random-mating is occurring in this population 
and genetic markers appear to be in Hardy-Weinberg equilibrium [Lockitch, 1974]. 
For the aforementioned reasons, and in accordance with family-based AFBAC 
association studies [Thomson, 1995], the unaffected individuals from the greater 
Mseleni region were considered to be a suitable control group for this study. The 
selected group for the pilot study comprised 40 unrelated individuals of age >30 
years. Only healthy subjects who had no family history of MID were included in 
the control group. 
(iii) HLA Association 
HLA is the major histocompatibility system which plays a dominant role in the 
genetic control of a variety of immune functions that influence disease 
susceptibility and resistance [Shreffler, 1977]. The region is particularly 
polymorphic comprising 4 different loci, each having between 6 and 22 different 
alleles [Payne, 1977]. 
In order to determine whether an association exists between the HLA complex and 
MID, blood specimens from affected and unaffected individuals were tested with 
probes for the class II HLA antigens, DRJ3 and DQJ3 [Ballo et al., 1996]. The study 
was undertaken at the Provincial laboratory for Tissue Immunology at the UCT 
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Medical School. PCR products were dot-blotted onto nylon membranes and probed 
for specific alleles. Hybridisation patterns were visualised by chemiluminescence 
according to the supplier's protocol [Boehringer Mannheim, Germany]. 
(iv) Histological Analysis 
Histological examination of cartilage tissue by means of electron microscopy has 
proven very useful in providing information about the ultrastructure of cartilage in 
persons affected with various forms of chondrodysplasia with an associated OA 
[Diab et al., 1994; Winterpacht et al., 1993]. 
In order to determine whether any specific ultrastructurally identifiable component of 
cartilage from individuals with MID had been altered, cartilage biopsies were 
sectioned for electron microscopy. The present study was performed in conjunction 
with Dr Doug Keene at the Research Laboratory, Shriner Hospital for Crippled 
Children, Portland, Oregon, USA. Femoral heads excised from affected adults 
requiring prosthetic hip joint replacement operations, became available for laboratory 
investigation. Six specimens of this type were collected following operation and 
prepared for electron microscopy. 
(v) Molecular Analysis: Comparison of allele frequencies at 
candidate gene loci 
In a non-Mendelising disorder such as MID, the trait may be multifactorial, being 
caused by the interaction of numerous genes with each other or with the 
environment. Classical linkage analysis is not suitable for detecting susceptibility 
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loci in these disorders, since it assumes that there is only one disease locus and 
relies on the use of an estimated value for penetrance of the trait. A more 
appropriate approach for the localisation of the gene(s) for a complex trait would 
be affected sibpair (ASP) analysis which tests for the sharing of alleles between 
sib pairs and has proven to be very powerful in mapping disease susceptibility 
loci [Weeks and Lathrop., 1995; Dyment et al., 1997; Nair et al., 1997]. The ASP 
method does not require the mode of inheritance to be known, and does not 
require extended families for investigation. This was important in MID as many 
family members were inaccessible and therefore limited numbers of people were 
available for study. Despite several trips to the Mseleni district, however, it was 
not possible to obtain the appropriate numbers of sibpairs which are required to 
validate the results of the ASP analysis. For this reason, a different level of 
association was investigated, based on the hypothesis that MID may be due to 
mutations in one or more candidate genes. The frequencies of alleles at the 
different candidate gene loci were determined to see whether any alleles were 
more frequent in affected individuals than in normal controls from the same 
geographic region. 
Venous blood (10ml) was obtained by venipuncture. Genomic DNA was 
extracted using the Genomix™ blood scale-up kit [Talent, Italy] (Appendix 1, 
section 1.1.). Synthetic oligonucleotide pairs for the intragenic and closely linked 
microsatellite markers (Table 7-1), were obtained commercially [Research 
Genetics, USA] or synthesized locally at the UCT. PCR reactions, to which d-
CTP32 had been added, were performed in a total reaction volume of 1 Oul 
(Appendix 1, section 2.1.2.). Reaction products were resolved on 6% PAGE gels 
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gels which were dried at sooc and autoradiographed 0/N at -100c (Appendix 1, 
section 2.1.3 .). 
Allele frequencies and heterozygote frequencies were calculated by allele counting. 
Concordance of genotype frequencies with Hardy-Weinberg equilibrium was 
tested by x2 goodness-of-fit test [Emery, 1986]. 
(vi) Mutation screening of COL2Al. 
Mutations in the COL2Al gene have been identified in several chondrodysplasias 
in which OA is a component or consistent complication (see Ch. 4, Table 4-I) . The 
present study could therefore not exclude the possibility of COL2Al being 
responsible for the development of, or of it harbouring a polymorphism which 
predisposes the carrier to, the MID phenotype. 
In collaboration with Dr Jarmo Korkko of the Allegheny University of the Health 
Sciences, Philadelphia, USA, the COL2Al exons in two affected individuals, one 
who had classical MID and one who was dwarfed, were screened using the 
intronic primers tabulated in Ch. 3 (Table 3-II) and the CSGE procedure (see 




No significant differences in the allele frequencies (p>0.05) of class II antigens, 
DRP and DQP, were found between affected individuals and healthy control 
subjects from the Mseleni district [Ballo et al. , 1996]. 
Histological Analysis 
Electron microscopic investigations of the cartilagenous region of the femoral 
heads revealed a large excess of broad-banded structures around the articular 
chondrocytes (Fig.7-1). These aggregates had a cross-striated appearance which is 
characteristic of collagen fibrils rich in type VI collagen [Roncuzzi et al., 1990]. 
Molecular Analysis: Comparison of Allele frequencies 
Allele frequencies in the unrelated MID individuals and the normal controls are 
tabulated and compared with reported figures [Research Genetics] in Table 7-1. 
The allele frequencies for the candidate gene markers were mostly similar to that 
of the control group (p<0.05; ·/> 3.48 with 1 degree of freedom [Emery, 1986]). 
The heterozygosity of the markers was generally similar between the two groups, 
and the published frequencies. In those instances where the values differed 
markedly from the literature (COL9A3, C0Ll0A1-D6S474, COLIOAl-
RFLP/HindIII, D8S539, and D19S2l5) the control and affected groups had 
similar frequencies. 
125 
Fig. 7-1. An electron.micrograph of an articular cartilage specimen showing a 
chondrocyte surrounded by a broad banded aggregate which is typical of type VI 
collagen. The insert is a high power view of the type VI collagen aggregates. 
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A significant difference between the affected and control groups was observed 
with the COL9Al marker, 509-12Bl , due to a significantly higher number of 
homozygous individuals in the affected group (Table 7-1). Although the 
homozygosity displayed with this marker was not restricted to one specific allele 
and was observed for all the alleles that were present in the two study groups, 
allele 8 had the highest homozygosity frequency (p<O. 00 I ; x2 > IO. 83 at I degree 
of freedom [Emery, 1986]) (Table 7-II). Family studies to assess the significance 
of this increased homozygosity and whether there was an underlying molecular 
mechanism which resulted in the apparent 'loss of heterozygosity', could not be 
undertaken due to the unavailability of DNA specimens from the appropriate 
relatives. 
Mutation screening of COL2Al 
No variations were observed in the CSGE patterns of the affected individuals 
when compared to that of the normal controls. 
7.4 DISCUSSION 
The clinical features, natural history and family clustering of the SED-like hip 
dysplasia component of MID could be explained on the basis of affected persons 
having a mild skeletal dysplasia, with a propensity to the development of severe and 
progressive degenerative OA. As the hip joints and the spine are most often affected, 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 7-II. The allele frequencies for marker 509-12Bl at the COL9Al locus in the affected 
(40 individuals) and control group (30 individuals) from Mseleni. The homozygosity 
frequency for each allele is listed. x2 was calculated at 1 degree of freedom. Aff=affected; 
con=controls. P=probability based on x2· 
Allele v Observed Observed 
(O/o) Homozygosity Homozygosity x2 p 
Aff:Con Aff (0/o) Con (0/o) 
1 5:3 3.6% 0.3% 10.58 <0.001 
2 7:11 3.6% 0.5% 5.28 <0.05 
3 25:25 14.3% 8.1% 1.30 >0.05 
4 4:9 0 0.1% 0.04 >0.05 
5 5:9 3.6% - 0.5% 5.14 <0.05 
6 21:18 10.7% 4.6% 2.28 <0.05 
7 4:2 3.6% 0.1% 25 <0.001 
8 27:21 25.0% 7.1 o/o 12.50 <0.01 
TOTAL HOMOZYGOSITY FREQUENCY: 
Affected: 64.3% Controls: 36.4% 
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As previously mentioned, a similar disorder with the geographic appellation 
"Handigodu disease" (HID) is present in a significant proportion of persons in 
two small, isolated caste groups of Kamataka, southern India [Agarwal et al., 
1994, 1997]. The clinical manifestations of this autosomal dominant disorder 
resemble those of MID and the issue of possible syndromic identity warrants 
consideration. 
Early investigations into the causative factors of MID focussed on the possibility 
that the disorder is the result of some unknown environmental factor. There are 
some parallels with Kashin-Beck disease, which occurs in Siberia which is 
reported to result from the ingestion of foodstuffs contaminated with aflatoxins 
[Nesterov, 1964]. Nevertheless, all attempts to identify a causative agent in the 
Mseleni environment have been inconclusive. 
As MID is confined to a specific population in a circumscribed area, genetic factors 
may be implicated. Indeed, the condition clusters in families, but there is no pattern 
of simple Mendelian inheritance. More complicated genetic mechanisms such as 
imprinting may be operative, but remain unproven. The situation is further 
complicated by the presence of a number of persons who have marked dwarfism, 
having a male mean height of 138.5cm and a female mean height of 136.2cm 
[Viljoen et al., 1993] in addition to the conventional osteoarthropathic 
manifestations. It may be supposed that these individuals are homozygous for the 
putative causative gene, but pedigree data do not support this concept. 
Until the present study, no molecular genetic studies on MID have been undertaken. 
The current investigations on ultrastructural analyses and genetic association was a 
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logistical extension of earlier genealogical studies of MID [Lockitch, 197 4] . 
HISTOLOGICAL ANALYSIS 
Early investigations using transmission electron microscopy to determine the effect of 
OA on cartilage ultrastructure, provided evidence of damage to the collagen 
framework and an increase in water content in OA [Meachim et al ., 1980]. In the 
present study, the accumulation of type VI collagen around the MID chondrocytes 
suggests that type VI collagen is abnormal in cartilage in excised femoral head 
specimens [Balle et al. , 1996]. This phenomenon has, however, been seen in other 
forms of OA. Roncuzzi et al. [ 1990] provided evidence that chondrocyte metabolism 
and the collagen network undergo modifications in osteoarthritic cartilage. It is of 
interest that type VI collagen appears to be deposited abnormally within the cell 
[Shikata et al. , 1993] and that mRNA expression is increased during wound healing 
[ Oono et al. , 1993 ], implying that type VI collagen expression may be increased in 
response to injury. The observation of excess type VI collagen around the 
chondrocytes in the present study was therefore considered to be a secondary 
generalised response in osteoarthropathies and not specific to the MID condition. 
HLA ANALYSIS 
Certain non-Mendelian conditions such as ankylosing spondylitis, juvenile diabetes 
and psoriasis, amongst others [Kidd et al., 1977; Nair et al., 1997], have shown a 
significant association with the HLA complex, implying the existence of an 
underlying genetic defect in these conditions. In the present study, however, no 
association was found between HLA and MID. 
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MOLECULAR ANALYSIS: COMPARISON OF ALLELE FREQUENCIES 
The principle of allelic association and its potential for human genetics was first 
shown in the context of sickle cell anaemia [Kan and Dozy, 1978]. This powerful 
yet simple strategy involves the comparison of allele frequencies in a randomly 
selected group of affected individuals with those of an unaffected control group. The 
detection of non-random allelic association provides a high resolution approach for 
the precise mapping of a disease locus and has been applied successfully in the 
location of the genes for conditions such as cystic fibrosis [Kerem et al., 1989] and 
myotonic dystrophy [Harley et al., 1991], amongst others. 
In the present study, no significant differences in allele frequencies were observed, 
between the affected and control groups, for markers from the COL2Al locus which 
encodes the major component of articular cartilage and which is mutated in many 
familial forms of SED and OA [Ala-Kokko et al., 1990; Winterpacht et al., 1994; 
Ballo et al., 1998]. The absence of association between the COL2Al markers and 
the MID phenotype corroborates the mutation screening results, which did not detect 
a genetic defect. The allele frequencies of markers from the COL6A2 and COL6A3 
loci were also investigated because of the type VI collagen aggregates around the 
chondrocytes which had been observed by electron microscopy. If there was a 
genetic modification of the type VI collagen genes which predisposed MID affected 
individuals to the condition, it is reasonable to presume that a change in allele 
frequencies between MID and normal controls would occur. No obvious differences 
in allele frequencies were, however, observed. The findings of the present study also 
ruled out the possibility of the other candidates, COL9A2, COL9A3, COLlOAl, 
COLl lAl, COL11A2, AGCl, DCN, FMOD, CRTLl, COMP, CCAL2, LUM, 
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CRTM and MMP3, being the major predisposing genes for MID. 
The COL9Al gene cannot, however, be excluded as a candidate. The increased 
allele homozygosity which was observed in the affected individuals makes it a 
possible candidate for the MID phenotype. These findings may be indicative of 
hemizygosity due to a null allele which renders the carrier susceptible to other 
genetic or environmental factors which may trigger the disorder. The significance of 
the apparent 'loss of heterozygosity' in COL9Al therefore needs to be examined in 
nuclear families. Interestingly, genotypes using the other intragenic marker, 509-
8B2, do not support an association between MID and this gene suggesting that either 
complicated molecular mechanisms are operative in the MID condition or that the 
homozygosity observed with 509-12Bl may be artifactual. However, the possibility 
of COL9Al being a determinant gene for this osteoarthritic condition gets support 
from earlier findings by Nakata et al. [1993] and Fassler et al. [1994]. Those authors 
reported osteoarthritic-like changes in transgenic mice with non-inflammatory 
degenerative joint disease harbouring COL9Al mutations. To date, no human 
chondrodystrophy has been associated with this gene. It is therefore necessary to 
follow-up this study with mutation screening of the COL9Al gene and to pursue 
nuclear families in order to determine the significance of the apparent 
homozygosity. 
In the event that COL9Al becomes excluded as a candidate due to the absence of a 
mutation, then it would be necessary to embark upon a large scale study of the MJD 
population group, taking into account the advances which have been made in linkage 
and association studies. The method of investigation that was used in the present 
study was the most appropriate in the absence of relatives and the lack of affected 
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sibpairs. A comparison of allele frequencies is not as powerful as ASP analysis and 
family-based studies for revealing susceptibility loci and the existence of one or 
more predisposing mutations in a population. For future studies ofthis type, it would 
be necessary to revisit the Mseleni district for the purpose of collecting biological 
material the appropriate numbers of affected sibling pairs or from nuclear families, 
and then to pursue the molecular investigations for susceptibility loci using 
advanced statistical methodology such as sibpair analysis, and family-based 
association studies [Kruglyak and Lander, 1995; Thomson, 1995]. 
It may also be reasonable to conduct further studies of environmental factors in light 
of improved strategies and advances since the investigations of the early 1970's. 
Early investigations for toxins produced by the fungus of ground-nuts, Aspergillus, 
failed to implicate its toxin in the aetiology of MID [ du Toit, 1979]. The absence in 
Zululand of the fungus of bread grain, Fusarium sporotrichiella, which causes 
Kashin-Beck disease, excluded its toxic product as a possible causative factor. 
However, in the last decade, fumonisins, which are mycotoxins produced by the 
mold Fusarium moni/iforme, were discovered. This mold is common on maize 
[Kommedahl and Windels, 1981, Marasas et al., 1984] and is apparently associated 
with increased bone and joint abnormalities [Sharby et al., 1973; Brown et al., 
1992b]. Since the diet of the Mseleni population includes maize, it would be feasible 
to investigate the presence of the fumonisin toxin in affected and unaffected persons. 
The pursuit of the gene(s) which are responsible for MID is more than an academic 
interest. The condition is extremely debilitating in an already impoverished 
community. A knowledge of the susceptibility genes and the environmental factors 
which trigger MID could have important implications for the lifestyle of this 
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community. Furthermore, it may provide valuable insights into the pathogenesis of 
the phenotypically similar HID condition and also conventional age-related OA. 
SECTION III 






Following the success in resolving the genetic defects in monogenic disorders, 
attention has now turned toward elucidating the genetics of complex traits. In the 
field of OA, major progress has been made in identifying the determinant genes 
which cause rare skeletal disorders in which OA is a secondary component. 
Molecular genetic strategies have led to the identification of alterations in the 
collagen genes and in the genes encoding non-collagenous components of the 
cartilage extracellular matrix. The COL2Al gene has been implicated in the 
aetiology of numerous skeletal dysplasias, in particular the SEDs. Likewise, the 
genes encoding certain other components of the cartilage extracellular matrix have 
been identified as the determinants of a spectrum of skeletal dysplasias in which 
OA is a component. 
The present study was focussed largely on monogenic skeletal dysplasias with OA 
as a secondary component, familial generalised OA without an underlying skeletal 
dysplasia and a chronic form of OA (MID) which is present in a geographical 
isolate in southern Africa. The genetic bases of several monogenic 
chondrodystrophies were elucidated. Two clinically characterised SED entities, 
namely NSED and SEDCT, were linked to a common COL2A 1 haplotype, and 
subsequently shown to carry a common disease-causing mutation in the gene. 
This larger unified group of SED patients will provide a means for acquiring 
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statistically significant data on disease aetiology, progress10n and modes of 
therapy. 
In a family of Caucasian descent, a mutation in COL2Al was found to underlie a 
Stickler-like syndrome. Analysis of data emerging from the current study with 
published literature was undertaken to determine whether genotype/phenotype 
correlations could be drawn on the type II collagenopathies. The present findings 
demonstrate that although most of the associated chondrodystrophies obey the 
phenotypic gradient of severity in type II collagen, phenotype/genotype 
correlations may be confounded by factors such as the position of the amino acid 
within the triplet repeat of the type II collagen helix (as seen in the South African 
family). For that matter, phenotypes cannot easily be deduced from the genotype 
or position of the mutation within the triple helical domain of COL2Al . 
In a second family of Caucasian descent, a defective COMP gene was found to 
cause a mild Ribbing type MED. Previously, COMP mutations were shown to be 
causative of the severe Fairbank type MED and the allelic condition, PSACH. The 
present study expands the range of phenotypes which can be produced by COMP 
mutations and therefore suggests that this gene may also play a role in milder 
forms ofOA. 
A gene responsible for FOA of early onset may, in theory, be identified by 
linkage analysis in an affected kindred. Candidate genes may also be screened by 
mutational analysis in affected individuals. In this regard, Vikkula et al. [1989] 
reported linkage of the COL2Al gene to OA in two large kindred. Mutational 
analysis of the gene did not, however, reveal the pathogenic mutation. It is 
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possible that their findings provided evidence of a susceptibility allele for the 
condition in those kindred rather than implicating COL2Al as the determinant 
gene. Further candidate screening may reveal susceptibility alleles in other 
candidate genes, a combination of which is required to develop the condition. 
Other studies have demonstrated genetic heterogeneity in FOA by finding non-
linkage to the COL2Al gene [Meulenbelt et al. , 1997]. Similarly, in the South 
African FOA family, no indication of linkage or association to one of the obvious 
candidate genes was observed, including COL2Al. It is also possible that the 
condition in this kindred is linked to an unknown bone or cartilage-expressed 
gene, and further investigation is warranted. It is also likely that the apparent 
Mendelian AD inheritance masks a slightly more complex inheritance pattern, 
which functions at least in a digenic manner (i.e. involving two, or even more, 
loci). In this instance using a greater number of 'affecteds only' in conjunction 
with candidate gene markers, could prove to be a powerful tool for identifying 
susceptibility alleles or predisposing polymorphisms. 
The identification of genes whose products are responsible for the structural 
integrity of articular cartilage, provided support for our approach in investigating 
these and other tissue-specific candidate genes in a pilot-scale investigation of the 
chronic disorder, MID. Association studies were our method of choice to locate 
the MID gene(s). This approach has previously led to the localization of several 
susceptibility loci for complex disorders. The use of highly polymorphic markers 
linked to candidate loci was expected to produce statistically significant results, 
even in the absence of family structures. The current research was based on the 
presumption that MID was homogeneous. For most loci, association between 
markers and the disease locus could be excluded. However, the significant 
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difference in heterozygote frequencies, which were observed between affected and 
control groups at the COL9Al locus, warrants further investigation. As suggested in Ch. 7, 
a major molecular investigation of MID needs to be undertaken, utilizing the appropriate 
sampling techniques which are required in accordance with more advanced strategies for 
linkage and association studies. Adequate sampling should also occur based on the premise 
that MID is a complex disorder, and should facilitate non-parametric analyses for disease 
gene localisation. 
The experimental findings reported in this thesis have contributed considerably to the 
elucidation of the molecular basis of several disorders in which degenerative OA is a 
feature. The lack of association between the wide range of obvious candidate articular 
cartilage genes and FOA and MID, however, provides scope for further research, and may 
indicate that these latter disorders are aetiologically more closely related to generalised 
OA. A future extension of the current research is the investigation of non-familial 
generalised OA in which there is a collection of clinically confirmed patient material 
which is adequate for general genetic screening. 
It seems prudent to conclude this thesis by saying that although establishing an association 
or linkage to a chromosomal locus is a crucial step in mapping a complex phenotype, the 
ultimate goal is to define the underlying mutation and to explore the functional 
mechanisms by which the disorder arises. With increasing health care costs and as the 
focus of medicine shifts to early detection and primary prevention, it becomes important to 
identify individuals who are at risk for common conditions. Moreover, insight into the 
causation of OA may have an immediate impact on the clinical management of affected 
individuals by suggesting novel therapeutic approaches. The ultimate long-term goal 
would be the prevention of this painful condition by clinical intervention at a 
presymtomatic stage, thereby alleviating the suffering and socioeconomic burden that the 
condition places on the population as a whole. 
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APPENDIX 
MATERIALS AND METHODS 
1. DNA Extraction: 
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DNA was extracted from frozen whole blood usmg a modified version of the 
Genomix™ [Talent, Italy] kit. Essentially, red blood cells were removed, white blood 
cells were lysed and DNA was released. The DNA was then bound to an ionic 
exchange resin and all cellular debris was washed away. Thereafter, the purified DNA 
was eluted from the resin. DNA was checked for purity by reading the absorbance of 
the DNA solution and determining the AuJOI A2so ratios. Digestion products of DNA 
samples which had been treated with restriction endonucleases were also examined. 
1.1. Genomix protocol: 
• 10ml frozen whole blood (collected in EDTA tubes) was thawed at 37°C, 2ml of 
Blood Washing solution (BWS) was added and the mixture centrifuged at 7000 
rpm for 15mins to pellet out the nuclei and cell debris. The supernatant was 
removed and the pellet resuspended in 5ml of BWS. Centrifugation was repeated 
at 7000 rpm. 
• The nuclei pellet was resuspended by vortexing in a mixture of 1ml of BWS and 
1ml of water. 
• Four ml of Lysing solution was added to the mixture which was then incubated at 
68°C for 7mins. 
• The lysate was transferred to a 14ml gel barrier tube and chloroform added to 
volume. The two phases were mixed by vigorously inverting the tube. 
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• The phases were separated by centrifugation at 5000 rpm at 10°C for 30mins. The 
upper aqueous phase was decanted into a 30ml glass tube [Corex, USA] which 
had been treated with diethyl pyrocarbonate [Maniatis et al., 1982]. 
• Eight ml of Precipitating solution was added to the aqueous phase and mixed by 
slow inversion until a filamentous DNA precipitate was visible. 
• The liquid phase was removed the sediment resuspended m 4ml of Ionic 
Exchange solution, and the suspension left 0/N at room temperature (RT). 
• Eight ml of ethanol was added, followed by inversion,. to precipate out the DNA. 
The DNA was washed twice in 5ml of 70% ethanol, transferred to a 1.5µ1 
microtest tube [Eppendorf, Germany] and centrifuged at 13 OOOrpm for lmin. All 
of the supernatant was removed and the DNA air-dried. The DNA pellet was 
finally resuspended in 200µ1 of sterile distilled deionised water (SDDW). 
1.2. Determination of DNA concentration and purity: 
The DNA concentration was calculated from the absorbance in water at 260nm (1 OD 
unit = 50µg/ml). The ratio of 260nm to 280nm absorbance values was used as a 
criterion of purity, a value greater than 1.5 being acceptable for DNA amplification by 
PCR. 
2. POLYMORPHISM ANALYSIS 
2.1. Microsatellite Polymorphism Analysis: 
2.1.1. DNA Primers 
Sequences for oligonucleotide primers for the amplification of di-, tri- or tetra-
nucleotides were either selected off the Genethon map (http://www.cephb.fr/ceph-
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genethon-map.html) or gleaned from scientific publications about the relevant gene. 
There were three ways of obtaining the primers viz: 
(i) small aliquots were provided by generous overseas contacts, 
(ii) the commercial company, Research Genetics, supplied them on order 
(iii) the Department of Biochemistry, UCT, synthesized them on order 
2.1.2. DNA amplification for genotyping and haplotype analysis 
Amplification of DNA was performed in a total volume of 1 Oul containing 200ng 
genomic DNA; 0.5uM of each primer; lX PCR buffer (50mM KCl/lOmM Tris pH 
8.4/ 1,5-2,5mM MgClz or supplied by BioTaq™), 200uM of each of dATP, dCTP, 
dGTP, dTTP [Boehringer Mannheim, Germany]; 0.5units Taq Polymerase 
[(BioTaq ™; ) or (GibcoBRL, )]. Visualisation of polymorphic bands was achieved 
by the direct incorporation of 0.05ul (0.5µCi) of a.-dCTP32 into each reaction. Each 
reaction mixture was overlaid with a drop of sterile liquid paraffin to prevent 
evaporation. Strict measures were taken throughout this and subsequent steps to 
ensure the safe use of radioactivity. All steps involving the handling of radioactive 
samples were conducted in an area which had been allocated for the use of 
radioactivity and the guidelines (compiled by the UCT Safety and Health committee) 
for safe usage were strictly adhered to. 
Annealing temperatures for the different pnmer sets were determined by the 
following calculation: 
4(G+C) + 2(A+T) - 5 
Cycling conditions were as follows: 
I cycle of denaturation at 94°C/3mins 
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30-35 cycles compnsmg denaturation at 94°C/30secs, annealing at 50°C-
650C/30sec, extension at 72°C/45secs 
1 cycle of extension at 72°C/5mins 
10µ1 of loading dye (0.25% bromophenol blue/ 0.25% xylene cyanol FF/ 40% (w/v) 
sucrose) was added to each 10µ1 of PCR product. 
2.1.3. Resolution of length polymorphisms by PAGE 
Gel Matrix 
A 6% denaturing polyacrylamide gel containing 15% urea, was made from a 40% 
stock solution of acrylogel 5, having an acrylamide to bisacrylamide ratio of 19: 1 
[BDH, UK]. Polymerisation was achieved by the addition of 10% ammonium 
persulphate (APS) [BDH, UK] and N'N'N'N' -tetramethylethylenediamine (TEMED) 
[BDH, UK]. 
Gel Size 
Gels were 422cm long , 333cm wide and 0.35mm thick. 
Electrophoresis Conditions 
Plates were cleaned and treated firstly with ethanol followed by acetone before 
pouring the gel. Gels were allowed to set for 45mins or longer. 
Samples were denatured at 98°C for 3-5mins and chilled on ice for 5-10mins before 
loading them onto the gel. 2-4µ1 of the denatured samples were loaded into each well 
and electrophoresed in lXTBE at 50°C and at 70W constant power for 2-3hrs 
(depending on the expected fragment size) using a standard sequencing apparatus 
164 
[OMEG Scientific, South Africa). Gels were dried onto 3MM paper [Schleicher and 
Schuell, Germany] on a slabgel drier for 1-2hrs at 80°C and autoradiographed at -
70°C for a period of 1-2nights. 
IOX TBE: 0.89M Tris/ 0.89M Boric Acid/ 0.02M EDTA pH8.0 
2.2. Mutation Analysis: 
2.2.1. SSCP 
2.2.1.1. DNA amplification for SSCP analysis 
Amplification of DNA was performed in a total volume of 10-20ul containing 200ng 
genomic DNA; 0.5uM of each primer; lX KCL buffer (supplied by BioTaq), 200uM 
(dATP, dCTP, dGTP, dTTP); 0.5units Taq Polymerase (either BioTaq). The SSCP 
mobility shifts were visualised by silver staining the gels. PCR products were sized on 
2% agarose gels and comparison with a 1kb MW marker [GibcoBRL, UK]. An equal 
volume of formamide loading dye (80% formamide/lOmM EDTA pH8/lmg/ml 
xylene cyanol FF) was added. 
2.2.1.2. Resolution of SSCP polymorphisms by MDE 
Gel Matrix 
A 0.5X MDE matrix (Hydrolink) either containing 10% glycerol, or without glycerol, 
and 0.6X TBE. Spacers and well-forming combs were 0.375mm thick. 
Gel Size 
Gels were 380cm long and 300cm wide and electrophoresed on a home-made system. 
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Electrophoresis Conditions 
Samples were denatured at 98°C for 5mins and chilled on ice for 10mins before 
loading onto the gel. 1 Oul of the denatured samples were loaded into each well and 
electrophoresed in 0.6XTBE at RT. at 2-lOW (depending on the expected fragment 
size) for 16hrs. 
Visualisation 
Gels were stained over three stages: 
20mins in 0.1 % AgN03 solution 
10-20mins in l.5%NaOH/l.5%formaldehyde (until SSCP mobility patterns were 
visible) 5-lOmins in 0.75% NaC03 (Often, it was impossible to remove the gel from 
the glassplates after staining. In that event, the gels were photocopied for permanent 
storage). 
2.2.2. DNA Sequencine: 
The Sequenase II (USB), and Sequitherm Excel I or Excel II ( Epicentre 
Technologies) sequencing kits were used to determine the nucleotide sequences of 
exonic fragments. The manufacturers' protocol for direct incorporation of 
radioisotope was adhered to in both instances. The radioisotope of choice was a-
dCTP32. 
Sequncing reactions were electrophoresed through 6% PAGE gels at a constant power 
of 70W. The duration of the run was determined by the length of the PCR fragment 
which was being investigated. The gels were dried on 80°C heated driers and 




Conformation Sensitive Gel 
Electrophoresis 
(CSGE) 
Principle: CSGE is used to detect single-base mismatches in DNA heteroduplexes that contain one __.. 
strand of wild-type and one strand of mutated DNA With the mildly denaturing solvents--ethylene 
glycol and formamide--we can amplify the tendency of single-base mismatches to produce 
conformational changes such as bends in the double helix and thereby increase the differential migration 
of DNA heteroduplexes and homoduplexes during gel electrophoresis. 
Specimen collection: --4-8 µl ofheteroduplexed PCR product from Genomic DNA 
I Reagent I Store at Additional information 
~-------------------- -
! 
i 500 ml acrylamide 40% w/v (lntermountain Scientific C-5550) 
polyacrylamide: RAP-solution I +4°C 2.02 g BAP (1 ,4-Bis[Acryolyl]Piperazine; Fluka 14470) 
I ! 5 ml dB20 Mix BAP with 5ml of dH20, then add to acrylamid 
---
Ethylene glycol ! rt Sigma E-9129 
r----
Formamide i -20°C I Gibco BRL 15515-026 store in single use aliquots (30ml). 
I I 
~--------·----!---~! -4-4.-4-m_M_ T_ri-s--1-4.-25_ m_ M_ T_a_u_n_·n_e-_0-.1-m_M_ E_D_T_A_ b_u_ff_e_r,-p-H- 9-.0-
20xTTE 





10 X loading buffer 










432 g Tris (Trizma Base, Sigma T1503) 
144 g Taurine (USB - 22072) 
8 g EDTA (Fisher - BP120-1) 
Add dB20 to 2000 ml 
DO NOT AUTOCLAVE THE TTE BUFFER ! 
USB - 32810 
Sigma - T-7024 
30ml Glycerol (Glycerin Fisher G33-500) 
.25 g Bromphenol Blue (Fisher B-392) 
.25 g Xylene cyanol FF (Sigma X-2751) 
Add H20 to 100 ml 
Intermountain Scientific C-5990 
Stratagene 300132 
~--! Sigma 
~---------- jinner Glass Plate (Kodak IB80520-size 37.5 x 43 cm) 
Plates,spacers, comb 
jOuter Glass Plate (Kodak IB80540-size 37.5 x 45 cm) 
!Gasket Kit (Kodak IB80600) 
!Comb and spacer set (FMC hnm, 37wells) 






i i Reagent !Final cone.I Volume Volume I for 1 gel for 2 gels I I 
j99: 1 acrylamide 40%:BAP 15% 75 ml 150 ml I 
I 
!20 X TTE buffer .5X 5 ml 10ml I 
lclHiO 
I 
68ml 136 ml ' 
I !Ethylene glycol 10% 20 ml 40ml ' 
!Formamide 15% 30 ml 60ml I ., 
jIO% Ammonium persulfate 2 ml 4ml I 
ITEMED 137 µl 274 µl ! 
Procedure: 
Enhance the heteroduplex formation by heating PCR products in the Perkin-Elmer Thermocycler as 
follows: Samples are heated at 98°C for 5 min then incubated at 68°C for 30 min. You can do this either 
as the last two cycles of PCR (easier...) or just before you put the samples on the CSGE gel. However, it 
is claimed that these steps increase the heteroduplex formation by only 5%, and I think that the most 
important function of these steps is to eliminate the appearance of the phantom bands. 
Pouring the gel: 
1. Clean glass plates with micro detergent, rinse well, then spray with 95% EtOH, and wipe each plate 
with a kimwipe. Coat the small plate with a small amount of Gene-Mate, let dry ( or with Acrylease, 
coat every 5th-8th time ..... ). 
2. Place spacers into long glass plate, cover with small plate and clamp. 
3. Tilt the glass plates at a 45°C angle. 
4. Gently pour the gel mixture between the two plates (if difficulties, use pipet or syringe). 
5. Insert the 37 well comb between the two glass plates. 
6. Clamp over the comb. 
7. Let polymerize for one hour. 
Running the gel: 
1. After gel is polymerized, remove lower spacer and comb, attach plates to the Sequencing Rig. 
2. Pour .5 X TTE Buffer into upper and lower chambers, check for leaks. 
3. Pre-run for 10-30min 40 watts (optional). 
4. Clean wells (with thin needle and syringe). Load Gel with appropriate amount (typically 3-6 µl) of 
PCR product mixed with 2-4 µl of loading dye. 
5. Loading the gel in an asymmetric pattern helps to minimize chances oflane misidentification. Load 
1 OOng of rod 74 marker on one lane ( optional). 
6. Run about 8-9 hat 40 watts for 300-500 base fragments (for 45cm glass plate). For your 
convenience, I recommend to use a power supply with timer .. .. lfyou experience problems (fuzzy 




Reading the gel 
1. Remove plates from gel apparatus and separate small plate from large plate. 
2. Stain gel with 200 µl concentrated ethidium bromide mixed with 2,000 ml tap HiO for 10 min in 
large staining tray. Minimize background by not overstaining. 
3. Visualize bands with a hand-held torch in dark room. If difficulties in finding the bands, transfer 
large enough piece of gel to blotting paper, and then visualize with UV torch. Note: Due to small 
amount of DNA and reflection from plate, bands may be hard to see by naked eye. Photography is 
critical to detection of band splits. 
4. Cut a relevant portion of the gel with a scalpel, transfer with a piece of blotting paper and release 
onto the transilluminator by wetting with water. 
5. Photography in this technique is used not only to document, but also to aid in detection of bands 
and doublet or triplets representing heteroduplexes of normal and mutant DNA regions. Bands 
must be photographed with a high quality camera and film apparatus. I recommend the use of high 
quality DCC camera with sufficient exposure time, brightness and contrast controls. 
Also, the Polaroid MP-4 camera and Polaroid type 57 film are effective, allowing careful focusing 
on close-ups of gel regions exhibiting bands. Multiple exposure times may be necessary to see 
bands of varying intensity in the same gel region. Photograph gel at varying apatures and exposures 
of varying times. Multiple short exposures may work better than one longer exposure to optimize 
band definition especially for bands that migrate close together. 
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